Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

Articles published in
J Gastroenterol Hepatol
    September 2021
  1. LOCKART I, Hajarizadeh B, Buckley N, Davison S, et al
    All cause hepatocellular carcinoma survival in the era of direct-acting antiviral therapy.
    J Gastroenterol Hepatol. 2021 Sep 14. doi: 10.1111/jgh.15687.
    >> Share

  2. YADA S, Sasaki S, Tokuno K, Yamashita Y, et al
    Hepatobiliary and Pancreatic: Extramammary Paget disease of the esophagus.
    J Gastroenterol Hepatol. 2021 Sep 2. doi: 10.1111/jgh.15665.
    >> Share

    August 2021
  3. ZHAO D, Xia L, Geng W, Xu D, et al
    Metformin suppresses IL-22 induced hepatocellular carcinoma by upregulating Hippo signaling pathway.
    J Gastroenterol Hepatol. 2021 Aug 25. doi: 10.1111/jgh.15674.
    >> Share

  4. EMORI T, Nuta J, Kawaji Y, Tamura T, et al
    Value of contrast-enhanced harmonic endoscopic ultrasound for diagnosing hepatic metastases of pancreatic cancer: a prospective study.
    J Gastroenterol Hepatol. 2021 Aug 16. doi: 10.1111/jgh.15661.
    >> Share

  5. OGAWA E, Nakamuta M, Furusyo N, Kajiwara E, et al
    Long-term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by DAAs.
    J Gastroenterol Hepatol. 2021 Aug 9. doi: 10.1111/jgh.15659.
    >> Share

  6. UENO M, Mano T, Kayahara T, Mizuno M, et al
    Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding: It's time to step forward.
    J Gastroenterol Hepatol. 2021 Aug 8. doi: 10.1111/jgh.15652.
    >> Share

  7. CHEN M, Hu G, Zhou X, Peng Z, et al
    Hsa_circ_0016788 regulates glycolysis and proliferation via miR-506-3p/PARP14 axis of hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2021 Aug 2. doi: 10.1111/jgh.15635.
    >> Share

    July 2021
  8. MAK J, Chan SM, Siu B, Lai J, et al
    Hepatobiliary and Pancreatic: A tree in the liver.
    J Gastroenterol Hepatol. 2021 Jul 27. doi: 10.1111/jgh.15623.
    >> Share

  9. ATTEBERRY P, Biederman B, Jesudian A, Lucero C, et al
    Mortality, Sepsis, and Organ Failure in Hospitalized Patients with Cirrhosis Vary by Type of Infection.
    J Gastroenterol Hepatol. 2021 Jul 22. doi: 10.1111/jgh.15633.
    >> Share

  10. SHI M, Sheng L, Lian M, Miao Q, et al
    Efficacy and safety of rifampicin in patients with persistent hepatocellular secretory failure.
    J Gastroenterol Hepatol. 2021 Jul 19. doi: 10.1111/jgh.15629.
    >> Share

  11. WU L, Huang XQ, Li N, Xie C, et al
    An MRI Modality for Non-invasively Distinguishing Progression of Liver Fibrosis by Visualizing Hepatic Platelet-Derived Growth Factor Receptor-Beta Expression in Mice.
    J Gastroenterol Hepatol. 2021 Jul 19. doi: 10.1111/jgh.15628.
    >> Share

  12. KRIGE J, Jonas E, Spence R, Bernon M, et al
    Letter to the editor: The complexities of predicting outcome in cirrhotic patients with acute variceal bleeding.
    J Gastroenterol Hepatol. 2021 Jul 12. doi: 10.1111/jgh.15622.
    >> Share

  13. ITO T, Hanafusa N, Soneda N, Isoai A, et al
    Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) against cirrhotic ascites in comparison with malignancy-related ascites.
    J Gastroenterol Hepatol. 2021 Jul 11. doi: 10.1111/jgh.15620.
    >> Share

    June 2021
  14. COUPER MR, Chennapragada M, Magoffin A
    Hepatobiliary and Pancreatic: A rare peribiliary lesion.
    J Gastroenterol Hepatol. 2021 Jun 29. doi: 10.1111/jgh.15556.
    >> Share

  15. ZULLO A, Soncini M, Bucci C, Marmo R, et al
    Clinical outcomes in cirrhotics with variceal or nonvariceal gastrointestinal bleeding: a prospective, multicenter cohort study.
    J Gastroenterol Hepatol. 2021 Jun 29. doi: 10.1111/jgh.15601.
    >> Share

  16. HO SY, Liu PH, Hsu CY, Ko CC, et al
    Tumor burden score as a new prognostic marker for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    J Gastroenterol Hepatol. 2021 Jun 22. doi: 10.1111/jgh.15593.
    >> Share

  17. PHRUEKSOTSAI S, Pinyopornpanish K, Euathrongchit J, Leerapun A, et al
    Dapagliflozin reduces hepatic and visceral fat in type-2 diabetes patients with non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2021 Jun 15. doi: 10.1111/jgh.15580.
    >> Share

  18. FAJARDO J, Nunez E, Szafranska J, Poca M, et al
    We report a patient who presented intrahepatic cholangitis and cholecystitis after SARS-CoV-2 infection.
    J Gastroenterol Hepatol. 2021 Jun 9. doi: 10.1111/jgh.15537.
    >> Share

    May 2021
  19. ZHOU J, Wang C, Chen Z
    Hepatobiliary and Pancreatic: Castleman disease of the pancreas diagnosed by endoscopic ultrasound.
    J Gastroenterol Hepatol. 2021 May 31. doi: 10.1111/jgh.15520.
    >> Share

  20. KANEKO S, Kurosaki M, Inada K, Kirino S, et al
    Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients.
    J Gastroenterol Hepatol. 2021 May 31. doi: 10.1111/jgh.15563.
    >> Share

  21. AGARWAL S, Sharma S, Kumar M, Venishetty S, et al
    Development of a machine learning model to predict bleed in esophageal varices in compensated advanced chronic liver disease: A proof of concept.
    J Gastroenterol Hepatol. 2021 May 28. doi: 10.1111/jgh.15560.
    >> Share

  22. MA HL, Chen SD, Zheng KI, Yu Y, et al
    The TA allele of rs2070673 in the CYP2E1 gene is associated with lobular inflammation and nonalcoholic steatohepatitis in patients with biopsy-proven nonalcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2021 May 24. doi: 10.1111/jgh.15554.
    >> Share

  23. TAK KY, Jang B, Lee SK, Nam HC, et al
    The prognostic role of M2BPGi compared with the HAP score in hepatocellular carcinoma patients receiving transarterial treatment.
    J Gastroenterol Hepatol. 2021 May 24. doi: 10.1111/jgh.15553.
    >> Share

  24. ZHAO JA, Nie W, Dong L, Liu W, et al
    A curcumin analogue GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circZNF83/miR-324-5p/CDK16 axis.
    J Gastroenterol Hepatol. 2021 May 12. doi: 10.1111/jgh.15545.
    >> Share

  25. CHANG H, Li J, Luo Y, Wu B, et al
    TFB2M activates aerobic glycolysis in hepatocellular carcinoma cells through the NAD(+) /SIRT3/HIF-1alpha signaling.
    J Gastroenterol Hepatol. 2021 May 12. doi: 10.1111/jgh.15548.
    >> Share

  26. YANG C, Liu J, Shi Q, Huang S, et al
    Effect of splenectomy on the outcomes in patients with cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    J Gastroenterol Hepatol. 2021 May 11. doi: 10.1111/jgh.15543.
    >> Share

  27. XIE JM, Liu JH, Sun YH, Li W, et al
    Hepatobiliary and Pancreatic: Endoscopic resection of biliary ductal tumour.
    J Gastroenterol Hepatol. 2021 May 9. doi: 10.1111/jgh.15518.
    >> Share

  28. HSU WF, Tsai PC, Chen CY, Tseng KC, et al
    Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (T-COACH).
    J Gastroenterol Hepatol. 2021 May 7. doi: 10.1111/jgh.15538.
    >> Share

  29. CHEN Z, Jiang H, Wang Y, Liang R, et al
    Three-day Postoperative Antibiotics Reduces Post-hepatectomy Infection Rate in HBV-related Hepatocellular Carcinoma.
    J Gastroenterol Hepatol. 2021 May 4. doi: 10.1111/jgh.15528.
    >> Share

    April 2021
  30. PUDIPEDDI A, Han J, Leong R
    Hepatobiliary and Pancreatic: Right upper quadrant pain and positive Murphy's sign.
    J Gastroenterol Hepatol. 2021 Apr 29. doi: 10.1111/jgh.15510.
    >> Share

  31. KAPURIA D, Bollipo S, Rabiee A, Ben-Yakov G, et al
    Roadmap to resuming care for liver diseases after coronavirus disease-2019.
    J Gastroenterol Hepatol. 2021;36:885-892.
    >> Share

    March 2021
  32. IWAKI M, Kessoku T, Ozaki A, Kasai Y, et al
    Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2021 Mar 11. doi: 10.1111/jgh.15487.
    >> Share

  33. SHARMA C, Cococcia S, Ellis N, Parkes J, et al
    Systematic review: Accuracy of The Enhanced Liver Fibrosis Test for diagnosing advanced liver fibrosis and cirrhosis.
    J Gastroenterol Hepatol. 2021 Mar 5. doi: 10.1111/jgh.15482.
    >> Share

  34. MOU H, Yang QA, Yu L, Wang T, et al
    PD-L1 expression in hepatocellular carcinoma and its correlation with clinicopathological characteristics.
    J Gastroenterol Hepatol. 2021 Mar 3. doi: 10.1111/jgh.15475.
    >> Share

  35. SATO M, Tateishi R, Yatomi Y, Koike K, et al
    Artificial intelligence in the diagnosis and management of hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2021;36:551-560.
    >> Share

  36. SU TH, Wu CH, Kao JH
    Artificial intelligence in precision medicine in hepatology.
    J Gastroenterol Hepatol. 2021;36:569-580.
    >> Share

  37. SUNG YS, Park B, Park HJ, Lee SS, et al
    Radiomics and deep learning in liver diseases.
    J Gastroenterol Hepatol. 2021;36:561-568.
    >> Share

  38. WONG GL, Yuen PC, Ma AJ, Chan AW, et al
    Artificial intelligence in prediction of non-alcoholic fatty liver disease and fibrosis.
    J Gastroenterol Hepatol. 2021;36:543-550.
    >> Share

  39. LEE HW, Sung JJY, Ahn SH
    Artificial intelligence in liver disease.
    J Gastroenterol Hepatol. 2021;36:539-542.
    >> Share

    February 2021
  40. WEST J, Gow PJ, Testro A, Chapman B, et al
    Exercise physiology in cirrhosis and the potential benefits of exercise interventions - a review.
    J Gastroenterol Hepatol. 2021 Feb 27. doi: 10.1111/jgh.15474.
    >> Share

  41. HEO YJ, Choi SE, Lee N, Jeon JY, et al
    Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model.
    J Gastroenterol Hepatol. 2021 Feb 18. doi: 10.1111/jgh.15465.
    >> Share

  42. JEONG Y, Lee KJ, Lee SJ, Shin YM, et al
    Radiofrequency ablation versus stereotactic body radiation therapy for small (
    J Gastroenterol Hepatol. 2021 Feb 17. doi: 10.1111/jgh.15442.
    >> Share

  43. WU Y, Xiang Q, Lv X, Xiang X, et al
    C2orf40 inhibits hepatocellular carcinoma through UBR5-dependent or p53-independent mechanisms.
    J Gastroenterol Hepatol. 2021 Feb 12. doi: 10.1111/jgh.15441.
    >> Share

  44. JIA Z, Zhang H, Li N
    Evaluation of clinical outcomes of radiofrequency ablation and surgical resection for hepatocellular carcinoma conforming to the Milan criteria: A systematic review and meta-analysis of recent randomized controlled trials.
    J Gastroenterol Hepatol. 2021 Feb 10. doi: 10.1111/jgh.15440.
    >> Share

  45. KIM JH, Park SW, Jung JH, Park DH, et al
    Bedside Risk-Scoring Model for Predicting 6-Week Mortality in Cirrhotic Patients Undergoing Endoscopic Band Ligation for Acute Variceal Bleeding.
    J Gastroenterol Hepatol. 2021 Feb 4. doi: 10.1111/jgh.15426.
    >> Share

  46. VADARLIS A, Antza C, Bakaloudi DR, Doundoulakis I, et al
    Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2021;36:311-319.
    >> Share

    January 2021
  47. TENG CF, Wang T, Shih FY, Shyu WC, et al
    Therapeutic Efficacy of Dendritic Cell Vaccine Combined with Programmed Death 1 Inhibitor for Hepatocellular Carcinoma.
    J Gastroenterol Hepatol. 2021 Jan 19. doi: 10.1111/jgh.15398.
    >> Share

  48. YOO BH, Kim SH, Baek YJ, Yeom JS, et al
    Hepatobiliary and Pancreatic: Liver abscess not responding to drainage and antibiotics.

    J Gastroenterol Hepatol. 2021 Jan 17. doi: 10.1111/jgh.15383.
    >> Share

  49. DING ZN, Dong ZR, Chen ZQ, Yang YF, et al
    Effects of HIF-1alpha and HIF-2alpha overexpression on hepatocellular carcinoma survival: A systematic review with meta-analysis.
    J Gastroenterol Hepatol. 2021 Jan 4. doi: 10.1111/jgh.15395.
    >> Share

  50. YI F, Guo X, Wang L, Xu X, et al
    Spontaneous splenorenal shunt may decrease the long-term survival of liver cirrhosis by compromising liver volume.
    J Gastroenterol Hepatol. 2021 Jan 3. doi: 10.1111/jgh.15386.
    >> Share

  51. GAO F, Zheng KI, Wang XB, Yan HD, et al
    Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients.
    J Gastroenterol Hepatol. 2021;36:204-207.
    >> Share

  52. LUM JHM, Cheah MCC, Leow WQ, Wan WK, et al
    Clinical profile of non-alcoholic fatty liver disease in nonobese patients.
    J Gastroenterol Hepatol. 2021;36:257-261.
    >> Share

  53. GRONBAEK H, Moller HJ, Saliba F, Zeuzem S, et al
    Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation.
    J Gastroenterol Hepatol. 2021;36:240-248.
    >> Share

    December 2020
  54. YAMAOKA K, Kodama K, Hiramatsu A, Ando Y, et al
    Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2020 Dec 16. doi: 10.1111/jgh.15377.
    >> Share

  55. MOCAN T, Nenu I, Craciun R, Sparchez Z, et al
    Treatment of hepatitis C virus infection in patients with hepatocellular carcinoma: truth or dare?
    J Gastroenterol Hepatol. 2020 Dec 16. doi: 10.1111/jgh.15376.
    >> Share

  56. TERRA C, Perez R
    Albumin for cirrhotic patients with infections unrelated to spontaneous bacterial peritonitis: A still no answered question.
    J Gastroenterol Hepatol. 2020;35:2290-2291.
    >> Share

    November 2020
  57. KIM DY, Lee HW, Kang W, Kim GM, et al
    Metabolic activity assessment by 18F-FDG PET in patients with hepatocellular carcinoma undergoing Yttrium-90 TARE.
    J Gastroenterol Hepatol. 2020 Nov 23. doi: 10.1111/jgh.15357.
    >> Share

  58. KIM KJ, Lee HW, Seong J
    Combination therapy with anti-TIM3 and radiation improves antitumor efficacy in murine hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2020 Nov 20. doi: 10.1111/jgh.15319.
    >> Share

  59. KIM S, Kim KH, Kim BK, Park JY, et al
    Lenvatinib is independently associated with the reduced risk of progressive disease when compared to sorafenib in patients with advanced hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2020 Nov 20. doi: 10.1111/jgh.15355.
    >> Share

  60. CRESPO J, Fernandez Carrillo C, Iruzubieta P, Hernandez-Conde M, et al
    MASSIVE IMPACT OF COVID-19 PANDEMIC ON GASTROENTEROLOGY AND HEPATOLOGY DEPARTMENTS AND DOCTORS IN SPAIN.
    J Gastroenterol Hepatol. 2020 Nov 12. doi: 10.1111/jgh.15340.
    >> Share

  61. HIRAOKA A, Kumada T, Kariyama K, Tada T, et al
    Clinical importance of muscle volume in lenvatinib for hepatocellular carcinoma: analysis adjusted with inverse probability weighting.
    J Gastroenterol Hepatol. 2020 Nov 10. doi: 10.1111/jgh.15336.
    >> Share

  62. CHEN H, Sung JJ
    Potentials of AI in Medical Image Analysis in Gastroenterology and Hepatology.
    J Gastroenterol Hepatol. 2020 Nov 3. doi: 10.1111/jgh.15327.
    >> Share

    October 2020
  63. WANG J, Ning J, Qian X, Zhang T, et al
    Deletion of Golgi protein73 delayed hepatocytes proliferation of mouse in the early stages of liver regeneration.
    J Gastroenterol Hepatol. 2020 Oct 29. doi: 10.1111/jgh.15315.
    >> Share

  64. TOSHIMA T, Yoshizumi T, Harada N, Ikegami T, et al
    Hepatobiliary and Pancreatic: A new strategy of endoscopic ultrasonography-guided internal drainage for a refractory hepatic abscess after liver transplantation.
    J Gastroenterol Hepatol. 2020 Oct 7. doi: 10.1111/jgh.15216.
    >> Share

  65. GAO F, Huang JF, Zheng KI, Pan XY, et al
    Development and validation of a novel non-invasive test for diagnosing fibrotic non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2020;35:1804-1812.
    >> Share

  66. WIJARNPREECHA K, Scribani M, Raymond P, Harnois DM, et al
    PNPLA3 gene polymorphism and overall and cardiovascular mortality in the United States.
    J Gastroenterol Hepatol. 2020;35:1789-1794.
    >> Share

  67. KITAGATAYA T, Suda G, Nagashima K, Katsurada T, et al
    Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy-associated hepatitis in Japan.
    J Gastroenterol Hepatol. 2020;35:1782-1788.
    >> Share

  68. SALMAN AA, Sultan AAEA, Abdallah A, Abdelsalam A, et al
    Effect of weight loss induced by laparoscopic sleeve gastrectomy on liver histology and serum adipokine levels.
    J Gastroenterol Hepatol. 2020;35:1769-1773.
    >> Share

    September 2020
  69. NAKAJIMA T, Karino Y, Hige S, Suii H, et al
    Factors affecting the recovery of hepatic reserve after sustained virologic response by direct-acting antiviral agents in chronic HCV-infected patients.
    J Gastroenterol Hepatol. 2020 Sep 29. doi: 10.1111/jgh.15280.
    >> Share

  70. YOKOYAMA K, Irie M, Tsuchiya N, Yamauchi E, et al
    Irsogladine maleate alters expression of a tight junction protein in portal hypertensive gastropathy.
    J Gastroenterol Hepatol. 2020 Sep 14. doi: 10.1111/jgh.15259.
    >> Share

  71. SANDI BB, Leao GS, de Mattos AA, de Mattos AZ, et al
    Long-term albumin administration in patients with cirrhosis and ascites: a meta-analysis of randomized controlled trials.
    J Gastroenterol Hepatol. 2020 Sep 10. doi: 10.1111/jgh.15253.
    >> Share

  72. PARK S, Jung J, Cho B, Kim SY, et al
    In reply to Huo et al.: Treating Small Hepatocellular Carcinoma: Stereotactic Body Radiation Therapy Versus Radiofrequency Ablation.
    J Gastroenterol Hepatol. 2020 Sep 9. doi: 10.1111/jgh.15250.
    >> Share

  73. YOU MW, Kim KW, Shim JJ, Pyo J, et al
    Impact of liver-stiffness measurement on hepatocellular carcinoma development in chronic hepatitis C patients treated with direct-acting antivirals: A systematic review and time-to-event meta-analysis.
    J Gastroenterol Hepatol. 2020 Sep 1. doi: 10.1111/jgh.15243.
    >> Share

  74. SHIMIZU Y, Tamura T, Kemmochi A, Owada Y, et al
    Oxidative stress and LXR agonist induce hepatocellular carcinoma in NASH model.
    J Gastroenterol Hepatol. 2020 Sep 1. doi: 10.1111/jgh.15239.
    >> Share

  75. KOGISO T, Hashimoto E
    Are low triglyceride levels the cause or an outcome of advanced liver fibrosis in elderly patients with nonalcoholic fatty liver disease?
    J Gastroenterol Hepatol. 2020;35:1459-1460.
    >> Share

  76. CHEN TP, Lai M, Lin WY, Huang KC, et al
    Metabolic profiles and fibrosis of nonalcoholic fatty liver disease in the elderly: A community-based study.
    J Gastroenterol Hepatol. 2020;35:1636-1643.
    >> Share

  77. ADAMS LA, Roberts SK, Strasser SI, Mahady SE, et al
    Nonalcoholic fatty liver disease burden: Australia, 2019-2030.
    J Gastroenterol Hepatol. 2020;35:1628-1635.
    >> Share

    August 2020
  78. DEL HOYO J, Lopez-Munoz P, Fernandez-de la Varga M, Garrido-Marin A, et al
    Hepatobiliary and Pancreatic: A fatal case of extensive splanchnic vein thrombosis in a patient with Covid-19.
    J Gastroenterol Hepatol. 2020 Aug 24. doi: 10.1111/jgh.15174.
    >> Share

  79. HIRAI M, Kinugasa H, Nouso K, Yamamoto S, et al
    Prediction of the prognosis of advanced hepatocellular carcinoma by TERT promoter mutations in circulating tumor DNA.
    J Gastroenterol Hepatol. 2020 Aug 24. doi: 10.1111/jgh.15227.
    >> Share

  80. CHUAH KH, Lai LL, Vethakkan SR, Nik Mustapha NR, et al
    Liver stiffness measurement in non-alcoholic fatty liver disease: Two is better than one.
    J Gastroenterol Hepatol. 2020;35:1404-1411.
    >> Share

  81. SHARMA A, Goel A, Moses V, Keshava SN, et al
    Anticoagulating Budd-Chiari syndrome patients presenting with variceal bleed: A retrospective study.
    J Gastroenterol Hepatol. 2020;35:1397-1403.
    >> Share

    July 2020
  82. HUO TI, Ho SY, Liu PH
    Is CT-enhanced clinical significant portal hypertension surrogate an authentic prognostic predictor for surgical hepatocellular carcinoma?
    J Gastroenterol Hepatol. 2020 Jul 27. doi: 10.1111/jgh.15203.
    >> Share

  83. KHAN A, Maheshwari S, Gupta K, Naseem K, et al
    Rate, Reasons, Predictors, and Burden of Readmissions After Transjugular Intrahepatic Portosystemic Shunt Placement.
    J Gastroenterol Hepatol. 2020 Jul 25. doi: 10.1111/jgh.15194.
    >> Share

  84. KIM KS, Kwon HM, Jung KW, Sang BH, et al
    Markedly prolonged QTc interval in end-stage liver disease and risk of 30-day cardiovascular event after liver transplant.
    J Gastroenterol Hepatol. 2020 Jul 13. doi: 10.1111/jgh.15179.
    >> Share

  85. CHEN A, Li S, Yao Z, Hu J, et al
    Adjuvant Transarterial Chemoembolization to Sorafenib in Unresectable Hepatocellular Carcinoma: A Meta-Analysis.
    J Gastroenterol Hepatol. 2020 Jul 11. doi: 10.1111/jgh.15180.
    >> Share

  86. SHANKER MD, Liu HY, Lee YY, Stuart KA, et al
    Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium.
    J Gastroenterol Hepatol. 2020 Jul 6. doi: 10.1111/jgh.15175.
    >> Share

  87. LAUBE R, Sabih AH, Strasser SI, Lim L, et al
    Palliative Care in Hepatocellular Carcinoma.
    J Gastroenterol Hepatol. 2020 Jul 6. doi: 10.1111/jgh.15169.
    >> Share

  88. YAMAMURA S, Nakano D, Hashida R, Tsutsumi T, et al
    Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.
    J Gastroenterol Hepatol. 2020 Jul 6. doi: 10.1111/jgh.15172.
    >> Share

  89. FAN J, Wang Q, Luo B, Chen H, et al
    Prevalence of prothrombotic factors in patients with Budd-Chiari syndrome or non-cirrhotic nonmalignant portal vein thrombosis: A hospital-based observational study.
    J Gastroenterol Hepatol. 2020;35:1215-1222.
    >> Share

    June 2020
  90. TANG RSY, Kyaw MH, Teoh AYB, Lui RNS, et al
    EUS guided cyanoacrylate injection to prevent rebleeding in hepatocellular carcinoma patients with variceal hemorrhage.
    J Gastroenterol Hepatol. 2020 Jun 30. doi: 10.1111/jgh.15168.
    >> Share

  91. TAN EZ, Lai LL, Vethakkan SR, Nik Mustapha NR, et al
    Modest alcohol intake is not associated with significant hepatic steatosis nor more severe liver disease among patient with diabetes mellitus.
    J Gastroenterol Hepatol. 2020 Jun 24. doi: 10.1111/jgh.15160.
    >> Share

  92. BRAHMANIA M, Wiskar K, Walley KR, Celi LA, et al
    Lower household income is associated with an increased risk of hospital readmission in patients with decompensated cirrhosis.
    J Gastroenterol Hepatol. 2020 Jun 20. doi: 10.1111/jgh.15153.
    >> Share

  93. SAKAI N, Yoshitomi H, Furukawa K, Takayashiki T, et al
    Outcome of interventional radiology for delayed postoperative hemorrhage in hepatobiliary and pancreatic surgery.
    J Gastroenterol Hepatol. 2020 Jun 11. doi: 10.1111/jgh.15140.
    >> Share

  94. CAO DB, Wang YS
    Gastrointestinal: Intrahepatic periportal masses with uncommon computed tomography patterns: Hepatic extramedullary hematopoiesis of primary mylofibrosis.
    J Gastroenterol Hepatol. 2020 Jun 7. doi: 10.1111/jgh.15069.
    >> Share

  95. GURKA MJ, Mack JA, Chi X, DeBoer MD, et al
    Use of Metabolic Syndrome Severity to Assess Treatment with Vitamin-E and Pioglitazone for Non-alcoholic Steatohepatitis.
    J Gastroenterol Hepatol. 2020 Jun 7. doi: 10.1111/jgh.15131.
    >> Share

  96. GOMEZ CIFUENTES JD, Sparkman J, Choi K, Sealock RJ, et al
    Regarding: Lui RN, Wong SH, Sanchez-Luna SA, et al. Overview of guidance for endoscopy during the coronavirus disease 2019 pandemic. J Gastroenterol Hepatol. 2020;35(5):749-759. doi:10.1111/jgh.15053.
    J Gastroenterol Hepatol. 2020 Jun 5. doi: 10.1111/jgh.15129.
    >> Share

  97. LEE HW, Ahn SH
    How do genetic variants affect our interpretation of non-invasive tests for non-alcoholic fatty liver disease?
    J Gastroenterol Hepatol. 2020;35:915-916.
    >> Share

  98. SHIN SK, Kim KO, Kim SH, Kwon OS, et al
    Exogenous 8-hydroxydeoxyguanosine ameliorates liver fibrosis through the inhibition of Rac1-NADPH oxidase signaling.
    J Gastroenterol Hepatol. 2020;35:1078-1087.
    >> Share

  99. NGUYEN TH, Wardell R, Chitturi S, Teoh N, et al
    When the liver gets stiff, the tough get moving.
    J Gastroenterol Hepatol. 2020;35:953-959.
    >> Share

  100. SAWADA K, Hayashi H, Nakajima S, Hasebe T, et al
    Non-alcoholic fatty liver disease is a potential risk factor for liver injury caused by immune checkpoint inhibitor.
    J Gastroenterol Hepatol. 2020;35:1042-1048.
    >> Share

  101. LIU WY, Zheng KI, Pan XY, Ma HL, et al
    Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2020;35:1057-1064.
    >> Share

  102. CHEN H, He C, Lv Y, Fan J, et al
    Long-term results of variceal bleeding management in 302 patients with chronic extrahepatic portal vein obstruction.
    J Gastroenterol Hepatol. 2020;35:1049-1056.
    >> Share

    May 2020
  103. HUO TI, Liu PH, Ho SY
    Treating small hepatocellular carcinoma: Stereotactic body radiation therapy vs RFA.
    J Gastroenterol Hepatol. 2020 May 31. doi: 10.1111/jgh.15126.
    >> Share

  104. LI Y, He HC, Zhou DL, Liu Q, et al
    Associations between lncRNA-related polymorphisms and hepatocellular carcinoma risk: A two-stage case-control study.
    J Gastroenterol Hepatol. 2020 May 26. doi: 10.1111/jgh.15118.
    >> Share

  105. LEE DH, Chung JW, Joo I, Suh KS, et al
    Varices on Computed Tomography Could Predict Survival after Hepatic Resection in Patients with Single Hepatocellular Carcinoma.
    J Gastroenterol Hepatol. 2020 May 26. doi: 10.1111/jgh.15117.
    >> Share

  106. XU X, Lei Y, Zhou H, Guo Y, et al
    beta-Arrestin1 involves in hepatocellular carcinoma metastasis via ERK mediated epithelial-mesenchymal transition.
    J Gastroenterol Hepatol. 2020 May 22. doi: 10.1111/jgh.15115.
    >> Share

  107. MA KW, So H, Cho DH, Oh JS, et al
    Durability and outcome of EUS-guided hepaticoduodenostomy using a fully covered metal stent for segregated right intrahepatic duct dilatation.
    J Gastroenterol Hepatol. 2020 May 4. doi: 10.1111/jgh.15089.
    >> Share

  108. KOBAYASHI T, Kanno K, Nguyen PT, Sugiyama A, et al
    Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of nonalcoholic steatohepatitis.
    J Gastroenterol Hepatol. 2020 May 4. doi: 10.1111/jgh.15088.
    >> Share

  109. YANG C, Yang H, Deng S, Zhang Y, et al
    Hepatobiliary and Pancreatic: Hepatic cystadenoma mimics hepatic cystic echinococcsis.
    J Gastroenterol Hepatol. 2020 May 3. doi: 10.1111/jgh.15044.
    >> Share

  110. WARRILLOW S, Fisher C, Tibballs H, Bailey M, et al
    Coagulation abnormalities, bleeding, thrombosis, and management of patients with acute liver failure in Australia and New Zealand.
    J Gastroenterol Hepatol. 2020;35:846-854.
    >> Share

  111. SINN DH, Kang D, Chang Y, Ryu S, et al
    Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study.
    J Gastroenterol Hepatol. 2020;35:833-839.
    >> Share

    April 2020
  112. YIP TC, Wong GL, Chan HL, Tse YK, et al
    Elevated testosterone increases risk of hepatocellular carcinoma in men with chronic hepatitis B and diabetes mellitus.
    J Gastroenterol Hepatol. 2020 Apr 28. doi: 10.1111/jgh.15079.
    >> Share

  113. TSENG CH, Tseng CM, Wu JL, Hsu YC, et al
    Magnitude of and Prediction for Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Taking Entecavir or Tenofovir Therapy: A Systematic Review.
    J Gastroenterol Hepatol. 2020 Apr 28. doi: 10.1111/jgh.15078.
    >> Share

  114. MAZIDI M, Ofori-Asenso R, Kengne AP
    Dietary Patterns Are Associated with Likelihood of Hepatic Steatosis among US Adults.
    J Gastroenterol Hepatol. 2020 Apr 26. doi: 10.1111/jgh.15076.
    >> Share

  115. WANG Y, Shen J, Feng S, Liang R, et al
    Hepatic Resection versus Transarterial Chemoembolization in Infiltrative Hepatocellular Carcinoma: A Multicenter Study.
    J Gastroenterol Hepatol. 2020 Apr 4. doi: 10.1111/jgh.15060.
    >> Share

  116. OGURA T, Nishioka N, Ueno S, Yamada M, et al
    Guidewire insertion under transluminal cholangioscopy guidance for a hepaticojejunostomy stricture resembling a pinhole (with video).
    J Gastroenterol Hepatol. 2020 Apr 4. doi: 10.1111/jgh.15050.
    >> Share

  117. SHARMA S, Kumar R, Rout G, Gamanagatti SR, et al
    Dabigatran as an oral anticoagulant in patients with Budd-Chiari syndrome post-percutaneous endovascular intervention.
    J Gastroenterol Hepatol. 2020;35:654-662.
    >> Share

    March 2020
  118. KIM JH, Kang SH, Lee M, Choi HS, et al
    Improved Detection of Hepatocellular Carcinoma by Dynamic CT in Cirrhotic Patients With Chronic Hepatitis B: A Multi-Center Study.
    J Gastroenterol Hepatol. 2020 Mar 28. doi: 10.1111/jgh.15046.
    >> Share

  119. TERASHIMA T, Honda M, Toyama T, Shimakami T, et al
    IL-28B variant as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy.
    J Gastroenterol Hepatol. 2020 Mar 16. doi: 10.1111/jgh.15035.
    >> Share

  120. GU L, Yao Q, Shen Z, He Y, et al
    Comparison of TDF versus ETV on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2020 Mar 16. doi: 10.1111/jgh.15036.
    >> Share

  121. HA I, Chung JW, Jang ES, Jeong SH, et al
    Comparison of the on-treatment risks for hepatocellular carcinoma between entecavir and tenofovir: A propensity score matching analysis.
    J Gastroenterol Hepatol. 2020 Mar 10. doi: 10.1111/jgh.15031.
    >> Share

  122. VENKATESH V, Rana SS, Kumar A, Aneja A, et al
    Hepatobiliary and Pancreatic: EUS-guided drainage of a ruptured amoebic liver abscess in a child.
    J Gastroenterol Hepatol. 2020 Mar 6. doi: 10.1111/jgh.15014.
    >> Share

  123. WU HM, Ni XX, Xu QY, Wang Q, et al
    Regulation of lipid-induced macrophage polarization through modulating PPAR-gamma activity affects hepatic lipid metabolism via TLR4/NF-kappaB signaling pathway.
    J Gastroenterol Hepatol. 2020 Mar 3. doi: 10.1111/jgh.15025.
    >> Share

  124. DALAL I, Cristelli R, Shahid H, Patel AV, et al
    Hepatobiliary and Pancreatic: Ectopic pancreas presented as a large paragastric mass.
    J Gastroenterol Hepatol. 2020 Mar 3. doi: 10.1111/jgh.15013.
    >> Share

  125. YOON JS, Lee HY, Chung SW, Kim SW, et al
    Prognostic impact of concurrent non-alcoholic fatty liver disease in patients with chronic hepatitis B-related hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2020 Mar 3. doi: 10.1111/jgh.15026.
    >> Share

  126. QIAN Y, Liu F, Zhang W, Zheng X, et al
    AQP9 suppresses hepatocellular carcinoma cell invasion through inhibition of HIF-1alpha expression under hypoxia.
    J Gastroenterol Hepatol. 2020 Mar 1. doi: 10.1111/jgh.15023.
    >> Share

  127. YE L, Yu Y, Zhao Y
    Icariin-induced miR-875-5p attenuates epithelial-mesenchymal transition by targeting hedgehog signaling in liver fibrosis.
    J Gastroenterol Hepatol. 2020;35:482-491.
    >> Share

    February 2020
  128. PARK S, Jung J, Cho B, Kim SY, et al
    Clinical Outcomes of Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma.
    J Gastroenterol Hepatol. 2020 Feb 13. doi: 10.1111/jgh.15011.
    >> Share

  129. LIU M, Shi J, Mu T, Wang Y, et al
    A systematic review of hepatic arterial infusion chemotherapy versus sorafenib in patients with hepatocellular carcinoma with portal vein tumor thrombosis.
    J Gastroenterol Hepatol. 2020 Feb 13. doi: 10.1111/jgh.15010.
    >> Share

  130. WALLACE MC, Samuelson S, Khoo T, Ooi J, et al
    The MAAPE score in intermediate and advanced hepatocellular carcinoma treated with Yttrium-90 resin microsphere radioembolization.
    J Gastroenterol Hepatol. 2020 Feb 9. doi: 10.1111/jgh.15008.
    >> Share

  131. ISHIZUKA K, Kon K, Lee HC, Arai K, et al
    Aging exacerbates high-fat diet-induced steatohepatitis through alteration in hepatic lipid metabolism in mice.
    J Gastroenterol Hepatol. 2020 Feb 6. doi: 10.1111/jgh.15006.
    >> Share

  132. YUE F, Xia K, Wei L, Xing L, et al
    Constant light exposure causes dysregulation of sphingolipids and promotes steatohepatitis in high-fat fed rats.
    J Gastroenterol Hepatol. 2020 Feb 6. doi: 10.1111/jgh.15005.
    >> Share

  133. KHOO S, Wong VW, Goh GB, Fan J, et al
    Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2020;35:320-325.
    >> Share

  134. SAHLMAN P, Nissinen M, Puukka P, Jula A, et al
    Genetic and lifestyle risk factors for advanced liver disease among men and women.
    J Gastroenterol Hepatol. 2020;35:291-298.
    >> Share

  135. HIROOKA M, Ochi H, Hiraoka A, Koizumi Y, et al
    Role of severe thrombocytopenia in preventing platelet count recovery in thrombocytopenic patients with chronic liver disease.
    J Gastroenterol Hepatol. 2020;35:299-304.
    >> Share

    January 2020
  136. IWANO K, Kurita A, Yazumi S
    Hepatobiliary and Pancreatic: Follicular cholangitis mimicking perihilar cholangiocarcinoma.
    J Gastroenterol Hepatol. 2020 Jan 28. doi: 10.1111/jgh.14966.
    >> Share

  137. PATERNOSTRO R, Kapzan L, Mandorfer M, Schwarzer R, et al
    Anemia and iron deficiency in compensated and decompensated cirrhosis: prevalence and impact on clinical outcomes.
    J Gastroenterol Hepatol. 2020 Jan 23. doi: 10.1111/jgh.14988.
    >> Share

  138. KOGISO T, Sagawa T, Kodama K, Taniai M, et al
    Long-term outcomes of non-alcoholic fatty liver disease and the risk factors for mortality and hepatocellular carcinoma in a Japanese population.
    J Gastroenterol Hepatol. 2020 Jan 23. doi: 10.1111/jgh.14989.
    >> Share

  139. KIRINO S, Tamaki N, Kaneko S, Kurosaki M, et al
    Validation of hepatocellular carcinoma risk scores in Japanese chronic hepatitis B cohort receiving nucleot(s)ide analog.
    J Gastroenterol Hepatol. 2020 Jan 23. doi: 10.1111/jgh.14990.
    >> Share

  140. SUGIURA R, Kinoshita K, Naruse H, Yamamoto Y, et al
    Hepatobiliary and Pancreatic: Hemosuccus pancreaticus due to an intraductal papillary mucinous neoplasm: A rare cause of obscure gastrointestinal bleeding.
    J Gastroenterol Hepatol. 2020 Jan 20. doi: 10.1111/jgh.14881.
    >> Share

  141. TOYODA H, Atsukawa M, Watanabe T, Nakamuta M, et al
    Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic HCV infection in a real-word setting: a large, multicenter study from Japan.
    J Gastroenterol Hepatol. 2020 Jan 16. doi: 10.1111/jgh.14982.
    >> Share

  142. XIE JM, Li W, Chen W
    Hepatobiliary and pancreatic: A case of stone-like carcinosarcoma in common bile duct.
    J Gastroenterol Hepatol. 2020 Jan 14. doi: 10.1111/jgh.14967.
    >> Share

  143. FUJIKAWA H, Araki M
    Hepatobiliary and Pancreatic: Abscess of the ligamentum teres hepatis.
    J Gastroenterol Hepatol. 2020 Jan 3. doi: 10.1111/jgh.14921.
    >> Share

  144. DAIJO K, Nakahara T, Inagaki Y, Nanba M, et al
    Risk factors for histological progression of nonalcoholic steatohepatitis analyzed from repeated biopsy cases.
    J Gastroenterol Hepatol. 2020 Jan 2. doi: 10.1111/jgh.14968.
    >> Share

  145. LEONG WL, Lai LL, Nik Mustapha NR, Vijayananthan A, et al
    Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2020;35:135-141.
    >> Share

  146. CHUNG GE, Heo NJ, Kim D, Kwak MS, et al
    Association between advanced fibrosis in fatty liver disease and overall mortality based on body fat distribution.
    J Gastroenterol Hepatol. 2020;35:90-96.
    >> Share

    December 2019
  147. ATSUKAWA M, Tsubota A, Takaguchi K, Toyoda H, et al
    Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema.
    J Gastroenterol Hepatol. 2019 Dec 27. doi: 10.1111/jgh.14965.
    >> Share

  148. LI Y, Zhang Y, Chen T, Huang Y, et al
    Aldosterone induces activation of primary mice hepatic stellate cell and liver fibrosis via NLRP3 inflammasome.
    J Gastroenterol Hepatol. 2019 Dec 20. doi: 10.1111/jgh.14961.
    >> Share

  149. SUDA T, Shirota Y, Hodo Y, Wakabayashi T, et al
    Hepatobiliary and Pancreatic: Intraductal papillary mucinous neoplasm rupture: A rare cause of pancreatic fistula.
    J Gastroenterol Hepatol. 2019 Dec 10. doi: 10.1111/jgh.14882.
    >> Share

  150. SOHN W, Kim JH, Cho JY
    Effect of acute kidney injury on long-term outcomes of spontaneous bacterial peritonitis in cirrhotic patients using the International Club of Ascites-acute kidney injury criteria.
    J Gastroenterol Hepatol. 2019 Dec 9. doi: 10.1111/jgh.14871.
    >> Share

  151. TAKATA K, Matsumoto K, Hirai F
    Hepatobiliary and Pancreatic: An intraperitoneal gallstone due to gallbladder perforation.
    J Gastroenterol Hepatol. 2019 Dec 9. doi: 10.1111/jgh.14918.
    >> Share

    November 2019
  152. JOSHITA S, Yamashita Y, Sugiura A, Uehara T, et al
    Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis.
    J Gastroenterol Hepatol. 2019 Nov 14. doi: 10.1111/jgh.14929.
    >> Share

  153. LIN HH, Liao SH, Huang YL, Liu KL, et al
    Hepatobiliary and Pancreatic: Biliary hamartoma manifests as liver cysts.
    J Gastroenterol Hepatol. 2019 Nov 11. doi: 10.1111/jgh.14821.
    >> Share

  154. HUANG WC, Liau JY, Jeng YM, Liu KL, et al
    Hepatocellular adenoma in Taiwan: Distinct ensemble of male predominance, overweight/obesity, and inflammatory subtype.
    J Gastroenterol Hepatol. 2019 Nov 7. doi: 10.1111/jgh.14903.
    >> Share

  155. VARELAS LJ, Klinge MJ, Malik SM, Borhani AA, et al
    IDIOPATHIC PNEUMATOSIS INTESTINALIS SECONDARY TO LACTULOSE USE IN PATIENTS WITH CIRRHOSIS.
    J Gastroenterol Hepatol. 2019 Nov 6. doi: 10.1111/jgh.14920.
    >> Share

  156. FRENCH J, van der Mei I, Simpson S Jr, Ng J, et al
    Increasing Prevalence of Primary Biliary Cholangitis in Victoria, Australia.
    J Gastroenterol Hepatol. 2019 Nov 6. doi: 10.1111/jgh.14924.
    >> Share

  157. WU CK, Yang SC, Liang CM, Li YC, et al
    The role of antibiotics in upper gastrointestinal bleeding among cirrhotic patients without major complications after endoscopic hemostasis.
    J Gastroenterol Hepatol. 2019 Nov 1. doi: 10.1111/jgh.14873.
    >> Share

  158. TAKANO K, Saeki C, Oikawa T, Hidaka A, et al
    IgM response is a prognostic biomarker of primary biliary cholangitis treated with ursodeoxycholic acid and bezafibrate.
    J Gastroenterol Hepatol. 2019 Nov 1. doi: 10.1111/jgh.14900.
    >> Share

    October 2019
  159. TOBARI M, Hashimoto E, Taniai M, Kodama K, et al
    The characteristics and risk factors of hepatocellular carcinoma in non-alcoholic fatty liver disease without cirrhosis.
    J Gastroenterol Hepatol. 2019 Oct 9. doi: 10.1111/jgh.14867.
    >> Share

    September 2019
  160. ZHAO S, Xu W, Xie YX, Chen WW, et al
    CXCR5(+) CD4(+) T cell subsets and their relationship to immune dysfunction in chronic hepatitis B associated liver cirrhosis.
    J Gastroenterol Hepatol. 2019 Sep 13. doi: 10.1111/jgh.14866.
    >> Share

  161. CHA SW, Kim SH, Kim YT, Sohn JH, et al
    Interaction between the tumor microenvironment and resection margin in different gross types of hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2019 Sep 4. doi: 10.1111/jgh.14848.
    >> Share

  162. ZHONG Y, Peng S, Yang Y
    Hepatobiliary and Pancreatic: Caroli syndrome: Egg-like sign on CT.
    J Gastroenterol Hepatol. 2019 Sep 1. doi: 10.1111/jgh.14822.
    >> Share

  163. LIU C, Ma L, Wang J, Li F, et al
    Prophylactic use of antibiotics in endoscopic injection of tissue adhesive for the elective treatment of gastric varices: A randomized controlled study.
    J Gastroenterol Hepatol. 2019;34:1486-1491.
    >> Share

  164. HEUCKE N, Wuensch T, Mohr J, Kaffarnik M, et al
    Non-invasive structure-function assessment of the liver by 2D time-harmonic elastography and the dynamic Liver MAximum capacity (LiMAx) test.
    J Gastroenterol Hepatol. 2019;34:1611-1619.
    >> Share

  165. KANG MK, Park JG, Lee HJ, Kim MC, et al
    Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2019;34:1633-1640.
    >> Share

    August 2019
  166. SOBOTKA LA, Risaliti C, Hinton A, Michaels A, et al
    Management of Hepatic Hydrothorax and Effect on Length of Stay, Mortality, Cost, and 30-Day Hospital Readmission.
    J Gastroenterol Hepatol. 2019 Aug 23. doi: 10.1111/jgh.14842.
    >> Share

  167. FENG Q, Yao J
    Hepatobiliary and Pancreatic: common bile duct stones with situs inversus totalis.
    J Gastroenterol Hepatol. 2019 Aug 14. doi: 10.1111/jgh.14833.
    >> Share

  168. PANDYA K, Liu K, Strasser SI
    Diaphragmatic paralysis after transarterial chemoembolization of hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2019 Aug 14. doi: 10.1111/jgh.14834.
    >> Share

  169. SAWADA Y, Kawaratani H, Kubo T, Fujinaga Y, et al
    Effect of furosemide on muscle cramps in patients with liver cirrhosis.
    J Gastroenterol Hepatol. 2019 Aug 5. doi: 10.1111/jgh.14820.
    >> Share

  170. PURCELL Y, Sartoris R, Paradis V, Vilgrain V, et al
    Influence of pre-treatment Tumour Growth Rate on objective response of hepatocellular carcinoma treated with transarterial chemoembolization.
    J Gastroenterol Hepatol. 2019 Aug 1. doi: 10.1111/jgh.14816.
    >> Share

  171. WONG GL, Wong VW
    Non-alcoholic fatty liver disease in Asia: How is it different from the West?
    J Gastroenterol Hepatol. 2019;34:1267-1268.
    >> Share

  172. RIDDIOUGH GE, Fifis T, Muralidharan V, Perini MV, et al
    Searching for the link; mechanisms underlying liver regeneration and recurrence of colorectal liver metastasis post partial hepatectomy.
    J Gastroenterol Hepatol. 2019;34:1276-1286.
    >> Share

  173. FUJII H, Imajo K, Yoneda M, Nakahara T, et al
    HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2019;34:1390-1395.
    >> Share

  174. LAI LL, Wan Yusoff WNI, Vethakkan SR, Nik Mustapha NR, et al
    Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
    J Gastroenterol Hepatol. 2019;34:1396-1403.
    >> Share

  175. TOMENO W, Imajo K, Kuwada Y, Ogawa Y, et al
    Distribution of liver stiffness in non-alcoholic fatty liver disease with higher fibrosis-4 index than low cut-off index.
    J Gastroenterol Hepatol. 2019;34:1411-1416.
    >> Share

  176. DARWEESH SK, Abd Alziz RA, Omar H, Sabry D, et al
    Secreted protein acidic and rich in cysteine gene variants: Impact on susceptibility and survival of hepatocellular carcinoma patients.
    J Gastroenterol Hepatol. 2019;34:1424-1431.
    >> Share

    July 2019
  177. LEAO GS, Neto GJ, de Freitas Jotz R, Alves de Mattos AA, et al
    Albumin for cirrhotic patients with extraperitoneal infections: a meta-analysis.
    J Gastroenterol Hepatol. 2019 Jul 28. doi: 10.1111/jgh.14791.
    >> Share

  178. KOBAYASHI T, Yoshikawa S, Takeuchi M, Terai S, et al
    Hepatobiliary and Pancreatic: AL amyloidosis presented as a hematoma in the hepatoduodenal ligament.
    J Gastroenterol Hepatol. 2019 Jul 24. doi: 10.1111/jgh.14744.
    >> Share

  179. GUPTA T, Lochan D, Verma N, Rathi S, et al
    Presence of Multidrug-resistant Infections at Admission Predict 28-day mortality in Acute Decompensation of Cirrhosis.
    J Gastroenterol Hepatol. 2019 Jul 23. doi: 10.1111/jgh.14788.
    >> Share

  180. GUEDES TP, Fernandes B, Pedroto I
    Hepatobiliary and Pancreatic: Symptomatic hepatic splenosis.
    J Gastroenterol Hepatol. 2019 Jul 18. doi: 10.1111/jgh.14743.
    >> Share

  181. YANG MJ, Lee GH, Kim JH, Hwang JC, et al
    Hepatobiliary and Pancreatic: Management of a benign bilio-enteric stricture by a novel covered stent with a long lasso.
    J Gastroenterol Hepatol. 2019 Jul 9. doi: 10.1111/jgh.14747.
    >> Share

  182. NISHIKAWA Y, Hirata A, Uza N
    Hepatobiliary and Pancreatic: Intrahepatic cholangiocarcinoma with intratumoral calcification mimicking hepatolithiasis.
    J Gastroenterol Hepatol. 2019 Jul 7. doi: 10.1111/jgh.14726.
    >> Share

  183. PATEL K, Mumtaz K, Li F, Luthra A, et al
    Index Admission Cholecystectomy for Acute Biliary Pancreatitis Favorably Impacts Outcomes of Hospitalization in Cirrhosis.
    J Gastroenterol Hepatol. 2019 Jul 1. doi: 10.1111/jgh.14775.
    >> Share

  184. IWAMOTO T, Maeda M, Saeki I, Hidaka I, et al
    Analysis of tolvaptan non-responders and outcomes of tolvaptan treatment of ascites.
    J Gastroenterol Hepatol. 2019;34:1231-1235.
    >> Share

  185. SAKAMOTO N, Suda G, Morikawa K, Ogawa K, et al
    Nutrition is often ignored in management of chronic liver diseases.
    J Gastroenterol Hepatol. 2019;34:1127-1128.
    >> Share

    June 2019
  186. ABBASNEZHAD A, Choghakhori R, Kashkooli S, Aalipour M, et al
    Effect of L-carnitine on liver enzymes and biochemical factors in hepatic encephalopathy: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2019 Jun 29. doi: 10.1111/jgh.14765.
    >> Share

  187. ZHU S, Du L, Xu D, Lu Z, et al
    Ascitic Fluid Total Protein, a useful marker in non-portal hypertensive ascites.
    J Gastroenterol Hepatol. 2019 Jun 27. doi: 10.1111/jgh.14768.
    >> Share

  188. REKIK S, Allaire M, Mumana A, Guyot E, et al
    Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis.
    J Gastroenterol Hepatol. 2019 Jun 24. doi: 10.1111/jgh.14763.
    >> Share

  189. SUN X, Ge X, Xu Z, Chen D, et al
    Identification of circRNA-miRNA-mRNA regulatory network in hepatocellular carcinoma by integrated analysis.
    J Gastroenterol Hepatol. 2019 Jun 20. doi: 10.1111/jgh.14762.
    >> Share

  190. LIU J, Shi Q, Xiao SP, Zhou C, et al
    Using transjugular intrahepatic portosystemic shunt as the first-line therapy in secondary prophylaxis of variceal hemorrhage.
    J Gastroenterol Hepatol. 2019 Jun 20. doi: 10.1111/jgh.14761.
    >> Share

  191. KURAMOTO K, Beppu T, Irie K, Kinoshita K, et al
    Hepatobiliary and Pancreatic: Intra-ductal biliary schwannoma.
    J Gastroenterol Hepatol. 2019 Jun 18. doi: 10.1111/jgh.14679.
    >> Share

  192. KIDA A, Matsuda K, Matsuda M, Sakai A, et al
    Hepatobiliary and Pancreatic: Biliary injury related to checkpoint inhibitor "pembrolizumab".
    J Gastroenterol Hepatol. 2019 Jun 14. doi: 10.1111/jgh.14677.
    >> Share

  193. KIM TS, Sinn DH, Kang W, Gwak GY, et al
    Hepatitis B virus DNA levels and overall survival in hepatitis B related hepatocellular carcinoma patients with low-level viremia.
    J Gastroenterol Hepatol. 2019 Jun 3. doi: 10.1111/jgh.14750.
    >> Share

  194. TADA T, Kumada T, Toyoda H, Tsuji K, et al
    Impact of albumin-bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time-dependent receiver operating characteristic.
    J Gastroenterol Hepatol. 2019;34:1066-1073.
    >> Share

    May 2019
  195. ZHANG RG, Tian X, Jia Q, Meng ZW, et al
    Hepatobiliary and Pancreatic: Chest tightness as a manifestation of cardiac metastasis related to hepatoma.
    J Gastroenterol Hepatol. 2019 May 29. doi: 10.1111/jgh.14680.
    >> Share

  196. MUDALIAR S, Liu K, Pavendranathan G, Kench JG, et al
    Hepatobiliary and Pancreatic: Kasabach-Merritt syndrome in adult.
    J Gastroenterol Hepatol. 2019 May 28. doi: 10.1111/jgh.14676.
    >> Share

  197. DEZSO K, Nagy P, Paku S
    Human liver regeneration following massive hepatic necrosis - two distinct patterns.
    J Gastroenterol Hepatol. 2019 May 14. doi: 10.1111/jgh.14721.
    >> Share

  198. SU TH, Liao SH, Hong CM, Liu CJ, et al
    NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging.
    J Gastroenterol Hepatol. 2019 May 7. doi: 10.1111/jgh.14705.
    >> Share

  199. SEMMLER G, Simbrunner B, Scheiner B, Schwabl P, et al
    Impact of farnesoid X receptor SNPs on hepatic decompensation and mortality in cirrhotic patients with portal hypertension.
    J Gastroenterol Hepatol. 2019 May 6. doi: 10.1111/jgh.14700.
    >> Share

  200. IDA S, Kojima Y, Hamaoka S, Urawa N, et al
    Validity of Japanese version of SARC-F questionnaire in patients with chronic liver disease.
    J Gastroenterol Hepatol. 2019;34:947-953.
    >> Share

    April 2019
  201. JIANG X, Liu F, Wang Y, Gao J, et al
    SPARC promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells and acquisition of cancer stem cell phenotypes.
    J Gastroenterol Hepatol. 2019 Apr 30. doi: 10.1111/jgh.14692.
    >> Share

  202. ZHANG C, Ge S, Wang J, Jing X, et al
    Epigenomic Profiling of DNA Methylation Reveals New Potential Biomarkers for Hepatocellular Carcinoma Diagnosis and Prognosis Prediction.
    J Gastroenterol Hepatol. 2019 Apr 30. doi: 10.1111/jgh.14694.
    >> Share

  203. XIANG Q, Zhou D, He X, Fan J, et al
    The zinc finger protein GATA4 induces MET and cellular senescence through the NF-kappaB pathway in hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2019 Apr 17. doi: 10.1111/jgh.14684.
    >> Share

  204. WATSON H, Guevara M, Vilstrup H, Gines P, et al
    Improvement of hyponatremia in cirrhosis is associated with improved complex information processing.
    J Gastroenterol Hepatol. 2019 Apr 9. doi: 10.1111/jgh.14683.
    >> Share

  205. HU KS, Tang B, Yuan J, Lu SX, et al
    A new sub-stage classification strategy for Barcelona Clinic Liver Cancer stage B patients with hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2019 Apr 1. doi: 10.1111/jgh.14673.
    >> Share

  206. LIU CH, Shih YL, Yang SS, Lin CL, et al
    Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East-Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis.
    J Gastroenterol Hepatol. 2019 Apr 1. doi: 10.1111/jgh.14672.
    >> Share

    March 2019
  207. CHEN CJ, Wang LC, Kuo HT, Fang YC, et al
    Late-evening snacking improves liver functions in patients with liver cirrhosis: A meta-analysis of randomized controlled trials.
    J Gastroenterol Hepatol. 2019 Mar 18. doi: 10.1111/jgh.14665.
    >> Share

  208. FOUAD TR, Abdelsameea E, Abdel-Razek W, Attia A, et al
    Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post-therapeutic outcome and prognostic indicators.
    J Gastroenterol Hepatol. 2019 Mar 14. doi: 10.1111/jgh.14659.
    >> Share

  209. YAMADA K, Mizukoshi E, Seike T, Horii R, et al
    Serum C16:1n7/C16:0 ratio as a diagnostic marker for non-alcoholic steatohepatitis Diagnosis of NASH using serum fatty acid.
    J Gastroenterol Hepatol. 2019 Mar 12. doi: 10.1111/jgh.14654.
    >> Share

  210. ZENG X, Li XX, Shi PM, Zhang YY, et al
    Utility of the EncephalApp Stroop Test for Covert Hepatic Encephalopathy Screening in Chinese Cirrhotic Patients.
    J Gastroenterol Hepatol. 2019 Mar 12. doi: 10.1111/jgh.14656.
    >> Share

  211. ROSSI UG, Rutigliani M, DeCensi A
    Hepatobiliary and Pancreatic: Sub-Glisson's capsule hepatic multiple nodular formations.
    J Gastroenterol Hepatol. 2019 Mar 4. doi: 10.1111/jgh.14618.
    >> Share

  212. YAMATO M, Sakai Y, Mochida H, Kawaguchi K, et al
    Adipose tissue-derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation.
    J Gastroenterol Hepatol. 2019 Mar 3. doi: 10.1111/jgh.14647.
    >> Share

  213. KUK N, Hodge A, Sun Y, Correia J, et al
    Human amnion epithelial cells and their soluble factors reduce liver fibrosis in a murine non-alcoholic steatohepatitis.
    J Gastroenterol Hepatol. 2019 Mar 1. doi: 10.1111/jgh.14643.
    >> Share

  214. TEOH NC
    Recent advances in the management of hepatocellular carcinoma: First, cut ... is the deepest or is it "no-touch" and exercise?
    J Gastroenterol Hepatol. 2019;34:481-482.
    >> Share

  215. KOBAYAKAWA M, Ohnishi S, Suzuki H
    Recent development of balloon-occluded retrograde transvenous obliteration.
    J Gastroenterol Hepatol. 2019;34:495-500.
    >> Share

    February 2019
  216. MAK LY, Ko M, To E, Wong DK, et al
    Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.
    J Gastroenterol Hepatol. 2019 Feb 20. doi: 10.1111/jgh.14637.
    >> Share

  217. HANAI T, Shiraki M, Watanabe S, Imai K, et al
    Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: a propensity score-matching analysis.
    J Gastroenterol Hepatol. 2019 Feb 18. doi: 10.1111/jgh.14635.
    >> Share

  218. LAI-HUNG WONG G, Sung JJ
    The emerging role of big data in gastroenterology and hepatology.
    J Gastroenterol Hepatol. 2019;34:307-308.
    >> Share

    January 2019
  219. ZHUGE Y, Liu Y, Xie W, Zou X, et al
    Expert consensus on the clinical management of pyrrolizidine alkaloid induced hepatic sinusoidal obstruction syndrome.
    J Gastroenterol Hepatol. 2019 Jan 22. doi: 10.1111/jgh.14612.
    >> Share

  220. KODAMA K, Kawaguchi T, Hyogo H, Nakajima T, et al
    Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis.
    J Gastroenterol Hepatol. 2019 Jan 22. doi: 10.1111/jgh.14608.
    >> Share

  221. LOHANA AK, Abid S, Sayani R, Tahir U, et al
    Hepatobiliary and Pancreatic: Bleeding in amyloid liver: A rare presentation of primary liver amyloidosis.
    J Gastroenterol Hepatol. 2019 Jan 21. doi: 10.1111/jgh.14567.
    >> Share

  222. TAKAHASHI K, Ozawa E, Nakao K, Aoki S, et al
    Hepatobiliary and Pancreatic: A procalcitonin-secreting and calcitonin-secreting pancreatic neuroendocrine carcinoma.
    J Gastroenterol Hepatol. 2019 Jan 21. doi: 10.1111/jgh.14568.
    >> Share

  223. SUNG J
    Renaissance in gastroenterology and hepatology.
    J Gastroenterol Hepatol. 2019;34:5-6.
    >> Share

  224. ITO T, Ishigami M, Ishizu Y, Kuzuya T, et al
    Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients.
    J Gastroenterol Hepatol. 2019;34:207-214.
    >> Share

  225. ISHIKAWA T, Sasaki R, Nishimura T, Matsuda T, et al
    Liver stiffness measured by transient elastography as predictor of prognoses following portosystemic shunt occlusion.
    J Gastroenterol Hepatol. 2019;34:215-223.
    >> Share

  226. LI C, Guo P, Okekunle AP, Ji X, et al
    Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients.
    J Gastroenterol Hepatol. 2019;34:256-262.
    >> Share

  227. CHOW JC, Wong GL, Chan AW, Shu SS, et al
    Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness.
    J Gastroenterol Hepatol. 2019;34:241-248.
    >> Share

    December 2018
  228. TOBARI M, Hashimoto E, Taniai M, Ikarashi Y, et al
    Characteristics of nonalcoholic steatohepatitis among lean patients in Japan: not uncommon and not always benign.
    J Gastroenterol Hepatol. 2018 Dec 27. doi: 10.1111/jgh.14585.
    >> Share

  229. LOPEZ RN, Al Rawahi Y, Stormon M, Chennapragada M, et al
    Hepatobiliary and Pancreatic: Hepatic arterioportal fistula: A novel and treatable feature of Alagille syndrome.
    J Gastroenterol Hepatol. 2018 Dec 18. doi: 10.1111/jgh.14506.
    >> Share

  230. ASPELUND G, Mahdi EM, Rothstein DH, Wakeman DS, et al
    Transitional care for patients with surgical pediatric hepatobiliary disease: choledochal cysts and biliary atresia.
    J Gastroenterol Hepatol. 2018 Dec 15. doi: 10.1111/jgh.14575.
    >> Share

  231. TEJEDOR-TEJADA J, Garcia-Pajares F, Madrigal Rubiales B
    Hepatobiliary and Pancreatic: Sertraline-induced vanishing bile duct syndrome treated with plasmapheresis.
    J Gastroenterol Hepatol. 2018 Dec 9. doi: 10.1111/jgh.14503.
    >> Share

    November 2018
  232. BOSSEN L, Gines P, Vilstrup H, Watson H, et al
    Serum sodium as a risk factor for hepatic encephalopathy in patients with cirrhosis and ascites.
    J Gastroenterol Hepatol. 2018 Nov 30. doi: 10.1111/jgh.14558.
    >> Share

  233. DEPREZ N, Dedeurwaerdere F, Desomer L, De Wulf D, et al
    Hepatobiliary and Pancreatic: Pyoderma gangrenosum of the pancreas successfully treated with infliximab.
    J Gastroenterol Hepatol. 2018 Nov 22. doi: 10.1111/jgh.14504.
    >> Share

  234. SUN Y, Lan X, Shao C, Wang T, et al
    Clinical Features of Idiopathic Portal Hypertension in China: A Retrospective Study of 338 Patients and Literature Review.
    J Gastroenterol Hepatol. 2018 Nov 21. doi: 10.1111/jgh.14552.
    >> Share

  235. WAKIZAKA K, Yokoo H, Kamiyama T, Ohira M, et al
    Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers.
    J Gastroenterol Hepatol. 2018 Nov 21. doi: 10.1111/jgh.14547.
    >> Share

  236. CHEN ZY, Liu YP, Zhou DJ
    Hepatobiliary and Pancreatic: Glycogenic hepatopathy in a patient with poorly controlled diabetes mellitus mimics a hepatic neoplasm.
    J Gastroenterol Hepatol. 2018 Nov 15. doi: 10.1111/jgh.14505.
    >> Share

  237. CAN SEZGIN G, Deniz K, Karahan OI, Gursoy S, et al
    Hepatobiliary and Pancreatic: Sclerosing extramedullary hematopoietic tumor involving hepatic hilum.
    J Gastroenterol Hepatol. 2018 Nov 12. doi: 10.1111/jgh.14507.
    >> Share

  238. CHENG YQ, Wang K, Zhang XP, Wei XB, et al
    Thrombocytopenia: a prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy.
    J Gastroenterol Hepatol. 2018 Nov 7. doi: 10.1111/jgh.14537.
    >> Share

  239. KOYA S, Kawaguchi T, Hashida R, Hirota K, et al
    Effects of In-Hospital Exercise on Sarcopenia in Hepatoma Patients Who Underwent Transcatheter Arterial Chemoembolization.
    J Gastroenterol Hepatol. 2018 Nov 7. doi: 10.1111/jgh.14538.
    >> Share

  240. ADACHI T, Nouso K, Miyahara K, Oyama A, et al
    Monitoring serum proangiogenic cytokines from hepatocellular carcinoma patients treated with sorafenib.
    J Gastroenterol Hepatol. 2018 Nov 6. doi: 10.1111/jgh.14535.
    >> Share

  241. DASHPUTRE AA, Nemecek BD, Kamal KM, Covvey JR, et al
    The relationship between a cirrhosis-specific comorbidity scoring system and healthcare utilization patterns.
    J Gastroenterol Hepatol. 2018 Nov 5. doi: 10.1111/jgh.14531.
    >> Share


  242. Asian Pacific Digestive Week (APDW). Connecting Excellence on Gastroenterology and Hepatology in Asia-Pacific, Seoul, Korea, 15-18 November 2018.
    J Gastroenterol Hepatol. 2018;33 Suppl 4:6-565.
    >> Share

    October 2018
  243. SOBOTKA LA, Hinton A, Conteh LF
    Disparities in the Treatment of Hepatocellular Carcinoma Based on Geographical Region Are Decreasing.
    J Gastroenterol Hepatol. 2018 Oct 21. doi: 10.1111/jgh.14515.
    >> Share

  244. GYODA Y, Imamura H, Ichida H, Yoshimoto J, et al
    Significance of hypovascular lesions on dynamic CT and/or EOB-enhanced MRI in patients with hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2018 Oct 21. doi: 10.1111/jgh.14510.
    >> Share

  245. ALLER MA, Arias N, Blanco-Rivero J, Arias JL, et al
    Hepatic encephalopathy: Sometimes more portal than hepatic.
    J Gastroenterol Hepatol. 2018 Oct 21. doi: 10.1111/jgh.14514.
    >> Share

  246. COOL J, Rosenblatt R, Kumar S, Lucero C, et al
    PORTAL VEIN THROMBOSIS PREVALENCE AND ASSOCIATED MORTALITY IN CIRRHOSIS IN A NATIONALLY REPRESENTATIVE INPATIENT COHORT.
    J Gastroenterol Hepatol. 2018 Oct 11. doi: 10.1111/jgh.14501.
    >> Share

  247. OGAWA Y, Honda Y, Kessoku T, Tomeno W, et al
    Wisteria floribunda agglutinin-positive Mac-2-binding protein and type 4 collagen 7S: useful markers for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2018;33:1795-1803.
    >> Share

    September 2018
  248. HIROOKA M, Hiraoka A, Ochi H, Koizumi Y, et al
    No-touch radiofrequency ablation is an ideal method to prevent intrahepatic metastasis of hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2018 Sep 17. doi: 10.1111/jgh.14476.
    >> Share

  249. MOLLER S, La Cour Sibbesen E, Madsen JL, Bendtsen F, et al
    The indocyanine green retention test in cirrhosis and portal hypertension. Accuracy and relation to severity of disease.
    J Gastroenterol Hepatol. 2018 Sep 17. doi: 10.1111/jgh.14470.
    >> Share

  250. LU J, Xiong XZ, Cheng NS
    Hepatobiliary and Pancreatic: Inflammatory myofibroblastic tumor of the liver mimicking intrahepatic cholangiocarcinoma with hilar lymph node metastasis.
    J Gastroenterol Hepatol. 2018 Sep 14. doi: 10.1111/jgh.14444.
    >> Share

  251. XU X, Cong L, Zhao Y
    Hepatobiliary and Pancreatic: Tumor to tumor metastasis from a primary insulinoma to a hepatic adenoma.
    J Gastroenterol Hepatol. 2018 Sep 6. doi: 10.1111/jgh.14443.
    >> Share

    August 2018
  252. KAKISAKA K, Suzuki Y, Fujiwara Y, Suzuki A, et al
    Lysophosphatidylcholine acyltransferase 3 is decreased in non-alcoholic steatohepatitis, resulting in caspase-independent hepatocyte death.
    J Gastroenterol Hepatol. 2018 Aug 30. doi: 10.1111/jgh.14461.
    >> Share

  253. KOZUKA R, Enomoto M, Sato-Matsubara M, Yoshida K, et al
    HLA-DQA1/DRB1 Polymorphism is Associated with the Development of Hepatocellular Carcinoma during Entecavir Treatment.
    J Gastroenterol Hepatol. 2018 Aug 30. doi: 10.1111/jgh.14454.
    >> Share

  254. KHAN F, Parikh MP, McCullough AJ
    Hepatobiliary and Pancreatic: Mauriac syndrome: A rare cause of elevated liver enzymes.
    J Gastroenterol Hepatol. 2018 Aug 16. doi: 10.1111/jgh.14381.
    >> Share

  255. WU SC, Chen WT, Muo CH, Hsu CY, et al
    A comparative study of subsequent liver cirrhosis risk in non- helicobacter pylori infected peptic ulcer patients with and without vagotomy: an Asian population cohort study.
    J Gastroenterol Hepatol. 2018 Aug 12. doi: 10.1111/jgh.14440.
    >> Share

  256. YAMADA N, Katano T, Hirata Y, Okada N, et al
    Serum Mac-2 Binding Protein Glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation.
    J Gastroenterol Hepatol. 2018 Aug 12. doi: 10.1111/jgh.14438.
    >> Share

  257. KENSTON SSF, Song X, Li Z, Zhao J, et al
    Mechanistic insight, diagnosis and treatment of ammonia induced hepatic encephalopathy.
    J Gastroenterol Hepatol. 2018 Aug 2. doi: 10.1111/jgh.14408.
    >> Share

  258. EUN HS, Cho SY, Lee BS, Kim S, et al
    Cytochrome P450 4A11 expression in tumor cells is a favorable prognostic factor for hepatocellular carcinoma patients.
    J Gastroenterol Hepatol. 2018 Aug 2. doi: 10.1111/jgh.14406.
    >> Share

  259. TARANTINO G, Porcu C, Arciello M, Andreozzi P, et al
    Prediction of carotid intima-media thickness in obese patients with low prevalence of comorbidities by serum copper bioavailability.
    J Gastroenterol Hepatol. 2018;33:1511-1517.
    >> Share

  260. WANG J, Ma L, Chen S, Xu L, et al
    Risk for the development of non-alcoholic fatty liver disease: A prospective study.
    J Gastroenterol Hepatol. 2018;33:1518-1523.
    >> Share

    July 2018
  261. KIM TH, Lee HA, Seo YS, Lee YR, et al
    Assessment and prediction of acute kidney injury in patients with decompensated cirrhosis with serum cystatin C and urine N-acetyl-beta-D-glucosaminidase.
    J Gastroenterol Hepatol. 2018 Jul 30. doi: 10.1111/jgh.14387.
    >> Share

  262. HIRAOKA A, Kumada T, Ogawa C, Kariyama K, et al
    Proposed After Direct Acting Antivirals Recommendation for Surveillance (ADRES) score for scheduled ultrasonography surveillance for hepatocellular carcinoma: multicenter analysis.
    J Gastroenterol Hepatol. 2018 Jul 11. doi: 10.1111/jgh.14378.
    >> Share

  263. YEAP SP, Harley H, Thompson R, Williamson KD, et al
    Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: diagnostic and management implications.
    J Gastroenterol Hepatol. 2018 Jul 10. doi: 10.1111/jgh.14376.
    >> Share

  264. WANG HW, Lai HC, Hu TH, Su WP, et al
    Modified FIB-4 index stratifies hepatocellular carcinoma risk in chronic hepatitis B patients on entecavir therapy.
    J Gastroenterol Hepatol. 2018 Jul 3. doi: 10.1111/jgh.14372.
    >> Share

    June 2018
  265. HUANG CF, Wang SC, Yeh ML, Huang CI, et al
    Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication.
    J Gastroenterol Hepatol. 2018 Jun 22. doi: 10.1111/jgh.14359.
    >> Share

  266. LEE DH, Ahn JH, Chung JW, Kim YJ, et al
    Varices on CT is Surrogate of Clinically Significant Portal Hypertension and can Predict Survival in Compensated Cirrhosis Patients.
    J Gastroenterol Hepatol. 2018 Jun 14. doi: 10.1111/jgh.14319.
    >> Share

  267. KAWAKAMI Y, Suzuki K, Miyake T, Hayashi Y, et al
    Hepatobiliary and Pancreatic: Hepatic alveolar echinococcosis mimics cholangiocarcinoma: Role of EUS-FNA.
    J Gastroenterol Hepatol. 2018 Jun 12. doi: 10.1111/jgh.14279.
    >> Share

  268. WANG YF, Chen HQ
    Hepatobiliary and Pancreatic: Spontaneous cholecystocutaneous fistula.
    J Gastroenterol Hepatol. 2018 Jun 12. doi: 10.1111/jgh.14285.
    >> Share

  269. LUO Q, Pang Z, Liu C, Liu X, et al
    Hepatobiliary and Pancreatic: Spontaneous hepatic hemorrhage caused by Ehlers-Danlos syndrome.
    J Gastroenterol Hepatol. 2018 Jun 11. doi: 10.1111/jgh.14278.
    >> Share

  270. HONG J, Wang K, Yu Y
    Hepatobiliary and Pancreatic: Malignant pancreatic perivascular epithelioid cell tumor mimicking pancreatic neuroendocrine tumor.
    J Gastroenterol Hepatol. 2018 Jun 10. doi: 10.1111/jgh.14272.
    >> Share

  271. YAMASHIMA M, Ozawa E, Ohnita K, Tabata K, et al
    Hepatobiliary and Pancreatic: Pancreatic mixed serous neuroendocrine neoplasm in von Hippel-Lindau disease.
    J Gastroenterol Hepatol. 2018 Jun 10. doi: 10.1111/jgh.14274.
    >> Share

  272. MATSUI N, Imajo K, Yoneda M, Kessoku T, et al
    Magnetic resonance elastography increases usefulness and safety of non-invasive screening for esophageal varices.
    J Gastroenterol Hepatol. 2018 Jun 4. doi: 10.1111/jgh.14298.
    >> Share

  273. LIU T, Xu L, Wang C, Chen K, et al
    Shikonin alleviates hepatic fibrosis and autophagy via inhibition of TGF-beta1/Smads pathway.
    J Gastroenterol Hepatol. 2018 Jun 4. doi: 10.1111/jgh.14299.
    >> Share

  274. DONG XQ, Li J, Liu H, Wang YW, et al
    Hepatobiliary and Pancreatic: A rare cause of decompensated liver cirrhosis.
    J Gastroenterol Hepatol. 2018 Jun 3. doi: 10.1111/jgh.14273.
    >> Share

  275. LIN YX, Fu YY, Cui T, Jia QB, et al
    Hepatobiliary and Pancreatic: Alpha fetoprotein producing distal cholangiocarcinoma metastasized to the ovary.
    J Gastroenterol Hepatol. 2018;33:1167.
    >> Share

  276. MANNAMI T, Fujiwara N, Ikeda G, Ebara H, et al
    Hepatobiliary and Pancreatic: A pancreatic stone causing biliary obstruction through major papillary impaction.
    J Gastroenterol Hepatol. 2018;33:1166.
    >> Share

  277. MAHADY SE, Adams LA
    Burden of non-alcoholic fatty liver disease in Australia.
    J Gastroenterol Hepatol. 2018;33 Suppl 1:1-11.
    >> Share

  278. KOO BK, Joo SK, Kim D, Bae JM, et al
    Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2018;33:1277-1285.
    >> Share

    May 2018
  279. AZUMA S, Kurita A, Yazumi S
    Hepatobiliary and Pancreatic: Burkitt lymphoma mimicking IgG4-related disease.
    J Gastroenterol Hepatol. 2018 May 28. doi: 10.1111/jgh.14276.
    >> Share

  280. KANG MK, Goo EJ, Kim SB, Kim KH, et al
    Hepatobiliary and Pancreatic: Intrahepatic cholangiocarcinoma with distant cutaneous metastases to the face.
    J Gastroenterol Hepatol. 2018 May 16. doi: 10.1111/jgh.14091.
    >> Share

  281. KATO S, Kuwatani M, Kawakubo K, Sugiura R, et al
    Hepatobiliary and Pancreatic: Pancreatic cancer with elevated serum IgG4 level due to multiple myeloma mimicking localized autoimmune pancreatitis.
    J Gastroenterol Hepatol. 2018 May 15. doi: 10.1111/jgh.14088.
    >> Share

  282. YASUDA S, Ishigami M, Ishizu Y, Kuzuya T, et al
    Substitutions in interferon sensitivity determining region and hepatocarcinogenesis after hepatitis C virus eradication.
    J Gastroenterol Hepatol. 2018 May 9. doi: 10.1111/jgh.14280.
    >> Share

  283. UOJIMA H, Hidaka H, Tanaka Y, Inoue T, et al
    Wisteria floribunda agglutinin-positive human Mac-2 binding protein in decompensated cirrhosis.
    J Gastroenterol Hepatol. 2018 May 8. doi: 10.1111/jgh.14277.
    >> Share

  284. MANATSATHIT W, Samant H, Kapur S, Ingviya T, et al
    Accuracy of liver stiffness, spleen stiffness, and LS-spleen diameter to platelet ratio score, in detection of esophageal varices: systemic review and meta-analysis.
    J Gastroenterol Hepatol. 2018 May 8. doi: 10.1111/jgh.14271.
    >> Share

  285. KOBAYASHI M, Ryozawa S, Nagata K
    Hepatobiliary and Pancreatic: A case of pure squamous cell carcinoma of the gallbladder.
    J Gastroenterol Hepatol. 2018;33:976.
    >> Share

  286. LAINO ME, Ragucci M, Klimstra DS, Mannelli L, et al
    Hepatobiliary and Pancreatic: Primary acinar cell carcinoma of the liver showing good response to chemotherapy.
    J Gastroenterol Hepatol. 2018;33:977.
    >> Share

  287. KAMIJO Y
    Is hepatic peroxisome proliferator-activated receptor alpha essential for the metabolic effects of fibrates?
    J Gastroenterol Hepatol. 2018;33:978-979.
    >> Share

  288. WONG GL
    Non-invasive assessments for liver fibrosis: The crystal ball we long for.
    J Gastroenterol Hepatol. 2018;33:1009-1015.
    >> Share

  289. MIN YW, Kim Y, Gwak GY, Gu S, et al
    Non-alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study.
    J Gastroenterol Hepatol. 2018;33:1053-1058.
    >> Share

  290. TAMAI T, Taniyama O, Oda K, Kasai A, et al
    Reduction effect of the quantity of radiation exposure and contrast media by image support system in transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2018;33:1115-1122.
    >> Share

  291. GUARINO M, Tortora R, de Stefano G, Coppola C, et al
    Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania.
    J Gastroenterol Hepatol. 2018;33:1123-1130.
    >> Share

    April 2018
  292. HAMOIR C, de Vos M, Clinckart F, Nicaise G, et al
    Hepatobiliary and Pancreatic: Nivolumab-related cholangiopathy.
    J Gastroenterol Hepatol. 2018 Apr 29. doi: 10.1111/jgh.14136.
    >> Share

  293. HABIB S, Patel N, Yarlagadda S, Hsu CH, et al
    Safety and efficacy of antibiotics among acutely decompensated cirrhosis patients.
    J Gastroenterol Hepatol. 2018 Apr 26. doi: 10.1111/jgh.14267.
    >> Share

  294. SHIRAISHI Y, Imai K, Yamashita YI, Nakao Y, et al
    Hepatobiliary and Pancreatic: Segmental arterial mediolysis of pancreaticoduodenal artery accompanied by acute pancreatitis and duodenal obstruction.
    J Gastroenterol Hepatol. 2018 Apr 24. doi: 10.1111/jgh.14138.
    >> Share

  295. ZHANG L, Gao H, Feng Y, Wang G, et al
    Hepatobiliary and Pancreatic: Obliterative portal venopathy found in Castleman disease variant of POEMS syndrome.
    J Gastroenterol Hepatol. 2018 Apr 24. doi: 10.1111/jgh.14084.
    >> Share

  296. CATERSON H, Liu K
    Hepatobiliary and Pancreatic: Rare hepatic vascular tumor presenting with hypertrophic osteoarthropathy.
    J Gastroenterol Hepatol. 2018 Apr 24. doi: 10.1111/jgh.14087.
    >> Share

  297. SESHACHALAM VP, Sekar K, Hui KM
    Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas.
    J Gastroenterol Hepatol. 2018 Apr 19. doi: 10.1111/jgh.14262.
    >> Share

  298. NIMRI L, Staikin K, Peri I, Yehuda-Shnaidman E, et al
    Ostreolysin induces browning of adipocytes and ameliorates hepatic steatosis.
    J Gastroenterol Hepatol. 2018 Apr 16. doi: 10.1111/jgh.14259.
    >> Share

  299. KODAMA K, Kawaoka T, Aikata H, Uchikawa S, et al
    Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
    J Gastroenterol Hepatol. 2018 Apr 12. doi: 10.1111/jgh.14152.
    >> Share

  300. LIN YX, Hu HJ, Li FY, Jia QB, et al
    Hepatobiliary and Pancreatic: Biliary reoperation for recurrent intrahepatic stones in patients with polysplenia syndrome.
    J Gastroenterol Hepatol. 2018 Apr 6. doi: 10.1111/jgh.14137.
    >> Share

  301. YANG MJ, Kim JH, Kim DJ, Hwang JC, et al
    Hepatobiliary and Pancreatic: EUS-guided reintervention for extraluminal stent migration after EUS-guided hepaticogastrostomy.
    J Gastroenterol Hepatol. 2018;33:772.
    >> Share

  302. KANG MK, Kim TN
    Hepatobiliary and Pancreatic: Hepatocellular carcinoma diagnosed by proptosis due to metastatic orbital mass.
    J Gastroenterol Hepatol. 2018;33:773.
    >> Share

  303. MIYATA T, Tajima H, Hirata M, Nakanuma SI, et al
    Phosphodiesterase III inhibitor attenuates rat sinusoidal obstruction syndrome through inhibition of platelet aggregation in Disse's space.
    J Gastroenterol Hepatol. 2018;33:950-957.
    >> Share

  304. SONG DS, Kim TY, Kim DJ, Kim HY, et al
    Validation of prognostic scores to predict short-term mortality in patients with acute-on-chronic liver failure.
    J Gastroenterol Hepatol. 2018;33:900-909.
    >> Share

    March 2018
  305. CHAN WK, Mustapha NRN, Mahadeva S, Wong VW, et al
    Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?
    J Gastroenterol Hepatol. 2018 Mar 30. doi: 10.1111/jgh.14150.
    >> Share

  306. TANDON P, Bishay K, Fisher S, Yelle D, et al
    Comparison of Clinical Outcomes Between Variceal and Non-Variceal Gastrointestinal Bleeding in Patients with Cirrhosis.
    J Gastroenterol Hepatol. 2018 Mar 30. doi: 10.1111/jgh.14147.
    >> Share

  307. PARK SW, Jun CH, Choi SK, Kim HJ, et al
    Hepatobiliary and Pancreatic: A black liver of Dubin-Johnson syndrome.
    J Gastroenterol Hepatol. 2018;33:562.
    >> Share

  308. VANBRUGGHE C, Tabchouri N, Louis G, Del Grande J, et al
    Hepatobiliary and Pancreatic: A rare form of autoimmune pancreatitis mimicking mixed-type intraductal papillary mucinous neoplasm.
    J Gastroenterol Hepatol. 2018;33:563.
    >> Share

  309. PAPALUCA T, Gow P
    Terlipressin: Current and emerging indications in chronic liver disease.
    J Gastroenterol Hepatol. 2018;33:591-598.
    >> Share

  310. ABE K, Takahashi A, Imaizumi H, Hayashi M, et al
    Utility of magnetic resonance elastography for predicting ascites in patients with chronic liver disease.
    J Gastroenterol Hepatol. 2018;33:733-740.
    >> Share

    February 2018
  311. KIM TH, Ku DH, Um SH, Lee HA, et al
    How can we improve the performance of MELDNa score in patients with HBV-related decompensated liver cirrhosis commencing antiviral treatment?
    J Gastroenterol Hepatol. 2018 Feb 20. doi: 10.1111/jgh.14128.
    >> Share

  312. WIGG AJ, Chin JK, Muller KR, Ramachandran J, et al
    A Chronic Disease Management Model for Cirrhosis is Cost-Effective: Analysis of a Randomized Controlled Trial.
    J Gastroenterol Hepatol. 2018 Feb 20. doi: 10.1111/jgh.14127.
    >> Share

  313. YAMADA T, Nakanishi Y, Okamura K, Tsuchikawa T, et al
    Impact of serum CA19-9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma.
    J Gastroenterol Hepatol. 2018 Feb 10. doi: 10.1111/jgh.14124.
    >> Share

  314. DOI H, Hayashi E, Arai J, Tojo M, et al
    Advanced cirrhosis drives enhanced B-cell differentiation resulting in hyperglobulinemia.
    J Gastroenterol Hepatol. 2018 Feb 10. doi: 10.1111/jgh.14123.
    >> Share

  315. HACZEYNI F, Yeh MM, Ioannou GN, Leclercq IA, et al
    Mouse Models Of Nonalcoholic Steatohepatitis: A Reflection On Recent Literature.
    J Gastroenterol Hepatol. 2018 Feb 9. doi: 10.1111/jgh.14122.
    >> Share

  316. OKUNO N, Hara K, Mizuno N, Kuwahara T, et al
    Efficacy of the 6-mm FCSEMS during EUS-guided hepaticogastrostomy as a primary biliary drainage for the cases estimated difficult ERCP: a prospective clinical study.
    J Gastroenterol Hepatol. 2018 Feb 9. doi: 10.1111/jgh.14112.
    >> Share

  317. WANG Q, Wang G, Wang Y, Liu C, et al
    ALKBH3 expression is associated with tumor recurrence and unfavorable prognosis in hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2018 Feb 7. doi: 10.1111/jgh.14117.
    >> Share

  318. ZHANG LH, Tai Y, Tong H, Lei XJ, et al
    Hepatobiliary and Pancreatic: Rare cause of obstructive jaundice by Trichosporon asahii.
    J Gastroenterol Hepatol. 2018;33:338.
    >> Share

  319. JAISWAL P, Jaiswal R, Attar BM, Dedania B, et al
    Hepatobiliary and Pancreatic: Massive hepatic cystic echinococcosis compressing inferior vena cava.
    J Gastroenterol Hepatol. 2018;33:339.
    >> Share

  320. PARENTE DB, Oliveira Neto JA, Brasil PEAA, Paiva FF, et al
    Preperitoneal fat as a non-invasive marker of increased risk of severe non-alcoholic fatty liver disease in patients with type 2 diabetes.
    J Gastroenterol Hepatol. 2018;33:511-517.
    >> Share

  321. DUAN X, Meng Q, Wang C, Liu Z, et al
    Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice.
    J Gastroenterol Hepatol. 2018;33:533-542.
    >> Share

    January 2018
  322. MANCEBO A, Varela M, Gonzalez-Dieguez ML, Navascues CA, et al
    Incidence and Risk Factors Associated with Hepatocellular Carcinoma Surveillance Failure.
    J Gastroenterol Hepatol. 2018 Jan 31. doi: 10.1111/jgh.14108.
    >> Share

  323. ZHANG F, Zhang J, Li X, Li B, et al
    The Notch signaling pathway regulates cell cycle in proliferating hepatocytes involved in liver regeneration.
    J Gastroenterol Hepatol. 2018 Jan 31. doi: 10.1111/jgh.14110.
    >> Share

  324. KAO JH, Yu ML, Chen CY, Peng CY, et al
    Twelve-week Ravidasvir plus ritonavir-boosted Danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study.
    J Gastroenterol Hepatol. 2018 Jan 18. doi: 10.1111/jgh.14096.
    >> Share

  325. KIM NH, Lee T, Cho YK, Kim BI, et al
    Impact of clinically evident portal hypertension on clinical outcome of patients with hepatocellular carcinoma treated by transarterial chemoembolization.
    J Gastroenterol Hepatol. 2018 Jan 3. doi: 10.1111/jgh.14083.
    >> Share

  326. FANG X, Liu LW, Dong J, Zhang J, et al
    A study about immunomodulatory effect and efficacy and prognosis of hUCMSCs in patients with CHB-induced decompensated liver cirrhosis.
    J Gastroenterol Hepatol. 2018 Jan 2. doi: 10.1111/jgh.14081.
    >> Share

  327. HARIMOTO N, Yugawa K, Ikegami T, Ohira M, et al
    Hepatobiliary and Pancreatic: Pregnancy induced hepatic veno-occlusive disease requiring liver transplantation.
    J Gastroenterol Hepatol. 2018;33:9.
    >> Share

  328. CRIMI F, Guido M, Pomerri F
    Hepatobiliary and Pancreatic: Hepatic nodules in a patient with familial adenomatous polyposis and colorectal adenocarcinoma.
    J Gastroenterol Hepatol. 2018;33:8.
    >> Share

  329. NAKAJIMA S, Tanaka H, Sawada K, Hayashi H, et al
    Polymorphism of receptor-type tyrosine-protein phosphatase delta gene in the development of non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2018;33:283-290.
    >> Share

  330. KAKISAKA K, Suzuki Y, Kataoka K, Okada Y, et al
    Predictive formula of coma onset and prothrombin time to distinguish patients who recover from acute liver injury.
    J Gastroenterol Hepatol. 2018;33:277-282.
    >> Share

  331. EDA K, Mizuochi T, Iwama I, Inui A, et al
    Zinc monotherapy for young children with presymptomatic Wilson disease: A multicenter study in Japan.
    J Gastroenterol Hepatol. 2018;33:264-269.
    >> Share

  332. DE JONGE P, de Man RA, van Buuren HR
    Gastrointestinal: Rare cause of hematemesis initially presenting as a bleeding gastric Dieulafoy's lesion.
    J Gastroenterol Hepatol. 2018;33:6.
    >> Share

  333. CHITTURI S, Wong VW, Chan WK, Wong GL, et al
    The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups.
    J Gastroenterol Hepatol. 2018;33:86-98.
    >> Share

    December 2017
  334. KAWASHITA Y, Morine Y, Saito Y, Takasu C, et al
    Role of HSF1 expression in the microenvironment of intrahepatic cholangiocarcinomas.
    J Gastroenterol Hepatol. 2017 Dec 26. doi: 10.1111/jgh.14078.
    >> Share

  335. ATSUKAWA M, Tsubota A, Kato K, Abe H, et al
    Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema.
    J Gastroenterol Hepatol. 2017 Dec 7. doi: 10.1111/jgh.14047.
    >> Share

  336. ZHOU LY, Ma YJ, Tian F
    Hepatobiliary and Pancreatic: Management of bleeding colonic varices in liver disease.
    J Gastroenterol Hepatol. 2017;32:1913.
    >> Share

  337. CHOUDHURY A, Kumar M, Sharma BC, Maiwall R, et al
    Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of 'golden window': A prospective study.
    J Gastroenterol Hepatol. 2017;32:1989-1997.
    >> Share

    November 2017
  338. HIRAOKA A, Otsuka Y, Kawasaki H, Izumoto H, et al
    Impact of muscle volume and function decline in patients undergoing surgical resection for hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2017 Nov 28. doi: 10.1111/jgh.14058.
    >> Share

  339. LI G, Brocker CN, Xie C, Yan T, et al
    Hepatic PPARalpha mediates the major metabolic effects of Wy-14643.
    J Gastroenterol Hepatol. 2017 Nov 15. doi: 10.1111/jgh.14046.
    >> Share

  340. SCHLEVOGT B, Rehkamper J, Hild B, Schmidt HH, et al
    Hepatobiliary and Pancreatic: Fulminant liver failure from diffuse leukemoid hepatic infiltration of melanoma.
    J Gastroenterol Hepatol. 2017;32:1795.
    >> Share

  341. LLOP E, Lopez M, de la Revilla J, Fernandez N, et al
    Validation of noninvasive methods to predict the presence of gastroesophageal varices in a cohort of patients with compensated advanced chronic liver disease.
    J Gastroenterol Hepatol. 2017;32:1867-1872.
    >> Share

  342. HIROOKA M, Koizumi Y, Imai Y, Nakamura Y, et al
    Clinical utility of multipolar ablation with a 3-D simulator system for patients with liver cancer.
    J Gastroenterol Hepatol. 2017;32:1852-1858.
    >> Share

    October 2017
  343. ARAI J, Goto K, Stephanou A, Tanoue Y, et al
    Predominance of regorafenib over sorafenib: restoration of membrane-bound MICA in hepatocellular carcinoma cells.
    J Gastroenterol Hepatol. 2017 Oct 21. doi: 10.1111/jgh.14029.
    >> Share

  344. OTANI I, Oka S, Tanaka S, Tsuboi A, et al
    Clinical significance of small-bowel villous edema in patients with liver cirrhosis-a capsule endoscopy study.
    J Gastroenterol Hepatol. 2017 Oct 10. doi: 10.1111/jgh.14016.
    >> Share

  345. CHOE EY, Lee YH, Choi YJ, Huh BW, et al
    Waist-to-calf ratio is an independent predictor of hepatic steatosis and fibrosis patients with type 2 diabetes.
    J Gastroenterol Hepatol. 2017 Oct 8. doi: 10.1111/jgh.14011.
    >> Share

  346. SHI SH, Feng XN, Wang ZY, Sun K, et al
    Pyogenic liver abscess related to intrahepatic bile duct stones: difficulties in infectious control and diagnosis of concomitant cholangiocarcinoma.
    J Gastroenterol Hepatol. 2017 Oct 6. doi: 10.1111/jgh.14010.
    >> Share

  347. DING F, Li Q, Duan X, Ye J, et al
    Hepatobiliary and Pancreatic: Ruptured aneurysm of intra-hepatic portal vein causing obstructive jaundice.
    J Gastroenterol Hepatol. 2017;32:1666.
    >> Share

  348. GILES H, Ross A, Gearry RB
    Gastrointestinal: Hepatic abscess after botulinum toxin type-A therapy for achalasia.
    J Gastroenterol Hepatol. 2017;32:1663.
    >> Share

  349. NGUYEN BD
    Hepatobiliary and Pancreatic: Hepatic necrobiotic xanthogranuloma.
    J Gastroenterol Hepatol. 2017;32:1667.
    >> Share

  350. ZHENG YX, Zhong X, Li YJ, Fan XG, et al
    Performance of scoring systems to predict mortality of patients with acute-on-chronic liver failure: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2017;32:1668-1678.
    >> Share

  351. PUIGVEHI M, Broquetas T, Coll S, Garcia-Retortillo M, et al
    Impact of anthropometric features on the applicability and accuracy of FibroScan((R)) (M and XL) in overweight/obese patients.
    J Gastroenterol Hepatol. 2017;32:1746-1753.
    >> Share

  352. LIN YJ, Gao XM, Pan WW, Gao S, et al
    A model to predict the onset of non-alcoholic fatty liver disease within 2 years in elderly adults.
    J Gastroenterol Hepatol. 2017;32:1739-1745.
    >> Share

    September 2017
  353. TADA T, Kumada T, Toyoda H, Kobayashi N, et al
    Hepatitis B virus core-related antigen levels predict progression to liver cirrhosis in hepatitis B carriers.
    J Gastroenterol Hepatol. 2017 Sep 15. doi: 10.1111/jgh.13989.
    >> Share

  354. SEO YS, Park SY, Kim MY, Kim SG, et al
    Serum cystatin C level is an excellent predictor of mortality in patients with cirrhotic ascites.
    J Gastroenterol Hepatol. 2017 Sep 14. doi: 10.1111/jgh.13983.
    >> Share

  355. ZHANG B, Zhang CG, Ji LH, Zhao G, et al
    Estrogen receptor beta selective agonist ameliorates liver cirrhosis in rats by inhibiting the activation and proliferation of hepatic stellate cells.
    J Gastroenterol Hepatol. 2017 Sep 7. doi: 10.1111/jgh.13976.
    >> Share

  356. ESO Y, Takai A, Arasawa S, Ueda Y, et al
    Hepatobiliary and Pancreatic: Granulomatous hepatitis due to disseminated bacillus Calmette-Guerin disease.
    J Gastroenterol Hepatol. 2017;32:1538.
    >> Share

  357. LIU PC, Wu MS, Hsieh MC, Suk FM, et al
    Hepatobiliary and Pancreatic: Development from gallbladder stone to gallstone ileus.
    J Gastroenterol Hepatol. 2017;32:1539.
    >> Share

  358. LV XH, Wang CH, Xie Y
    Arsenic trioxide combined with transarterial chemoembolization for primary liver cancer: A meta-analysis.
    J Gastroenterol Hepatol. 2017;32:1540-1547.
    >> Share

  359. JIA Z, Paz-Fumagalli R, Frey G, Sella DM, et al
    Single-institution experience of radioembolization with yttrium-90 microspheres for unresectable metastatic neuroendocrine liver tumors.
    J Gastroenterol Hepatol. 2017;32:1617-1623.
    >> Share

  360. CRESCI GA, Glueck B, McMullen MR, Xin W, et al
    Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury.
    J Gastroenterol Hepatol. 2017;32:1587-1597.
    >> Share

    August 2017
  361. GERAGE AM, Ritti-Dias RM, Balagopal B, de Oliveira Conceicao RD, et al
    Physical activity levels and hepatic steatosis: a longitudinal follow up study in adults.
    J Gastroenterol Hepatol. 2017 Aug 30. doi: 10.1111/jgh.13965.
    >> Share

  362. LEE EC, Park SJ, Han SS, Shim JR, et al
    Risk Prediction of Post-Hepatectomy Liver Failure in Patients with Perihilar Cholangiocarcinoma.
    J Gastroenterol Hepatol. 2017 Aug 26. doi: 10.1111/jgh.13966.
    >> Share

  363. CHIRAPONGSATHORN S, Bunraksa W, Chaiprasert A, Punpanich D, et al
    Adding C-reactive protein and procalcitonin to the MELD score improves mortality prediction in patients with complications of cirrhosis.
    J Gastroenterol Hepatol. 2017 Aug 25. doi: 10.1111/jgh.13928.
    >> Share

  364. AMPUERO J, Montoliu C, Simon-Talero M, Aguilera V, et al
    Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression.
    J Gastroenterol Hepatol. 2017 Aug 2. doi: 10.1111/jgh.13917.
    >> Share

  365. HO CM, Wu CH, Liau JY
    Hepatobiliary and Pancreatic: Biliary intra-epithelial neoplasia.
    J Gastroenterol Hepatol. 2017;32:1424.
    >> Share

  366. MATSUMURA K, Hashimoto D, Umezaki N, Nakagawa S, et al
    Hepatobiliary and Pancreatic: Portal vein stent for local recurrence of bile duct cancer.
    J Gastroenterol Hepatol. 2017;32:1425.
    >> Share

    July 2017
  367. DE SANTIS A, Nardelli S, Bassanelli C, Lupo M, et al
    The modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt.
    J Gastroenterol Hepatol. 2017 Jul 28. doi: 10.1111/jgh.13907.
    >> Share

  368. ELNEGOULY M, Umgelter K, Safi W, Hapfelmeier A, et al
    Elevated Cardiac Troponin T in Cirrhotic Patients with Emergency Care Admissions is Associated with Mortality.
    J Gastroenterol Hepatol. 2017 Jul 20. doi: 10.1111/jgh.13902.
    >> Share

  369. KIMER N, Pedersen JS, Tavenier J, Christensen JE, et al
    Rifaximin has minor effects on bacterial composition, inflammation and bacterial translocation in cirrhosis; A randomized trial.
    J Gastroenterol Hepatol. 2017 Jul 3. doi: 10.1111/jgh.13852.
    >> Share

  370. ZHONG X, Liu H
    Honokiol attenuates Diet-Induced Nonalcoholic Steatohepatitis by regulating macrophage polarization through activating PPARgamma.
    J Gastroenterol Hepatol. 2017 Jul 2. doi: 10.1111/jgh.13853.
    >> Share

  371. COSTA JM, Costa D, Vieira F, Rolanda C, et al
    Hepatobiliary and Pancreatic: Giant hepatomegaly from hepatic hemagiomatosis.
    J Gastroenterol Hepatol. 2017;32:1285.
    >> Share

  372. AGARWAL J, Hasan A, Mehrotra M
    Hepatobiliary and Pancreatic: Hepatogastric fistula.
    J Gastroenterol Hepatol. 2017;32:1284.
    >> Share

  373. MORIKAWA M, Suzuki H, Obata-Yasuoka M, Kasai M, et al
    Association of antenatal antithrombin activity with perinatal liver dysfunction: A prospective multicenter study.
    J Gastroenterol Hepatol. 2017;32:1378-1386.
    >> Share

  374. LOONG TC, Wei JL, Leung JC, Wong GL, et al
    Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2017;32:1363-1369.
    >> Share

    June 2017
  375. KIM BS, Seo YS, Kim YS, Lee CH, et al
    Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus-related advanced fibrosis or cirrhosis.
    J Gastroenterol Hepatol. 2017 Jun 30. doi: 10.1111/jgh.13854.
    >> Share

  376. FUJITA K, Niki T, Nomura T, Oura K, et al
    Serum galectin-9 levels are correlated to liver fibrosis regardless of chronic inflammation or hepatocellular carcinoma complications.
    J Gastroenterol Hepatol. 2017 Jun 15. doi: 10.1111/jgh.13851.
    >> Share

  377. SZKLARUK J, Kaya D, Wei W
    Evaluation of the Added Value of Imaging the Pelvis in Patients with Hepatocellular Cancer.
    J Gastroenterol Hepatol. 2017 Jun 14. doi: 10.1111/jgh.13847.
    >> Share

  378. KIM BH, Lim YS, Kim EY, Kong HJ, et al
    Temporal Improvement in Survival of Patients with Hepatocellular Carcinoma in a Hepatitis B Virus-Endemic Population.
    J Gastroenterol Hepatol. 2017 Jun 14. doi: 10.1111/jgh.13848.
    >> Share

  379. ZHANG X, Li J, Shen F, Lau WY, et al
    Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2017 Jun 6. doi: 10.1111/jgh.13843.
    >> Share

  380. LING QA, Yo J, Gerstenmaier JF, Kemp W, et al
    Hepatobiliary and Pancreatic: Hepatic and mesenteric aneurysms with biloma formation.
    J Gastroenterol Hepatol. 2017;32:1134.
    >> Share

  381. BERTRAIS S, Boursier J, Ducancelle A, Oberti F, et al
    Prognostic durability of liver fibrosis tests and improvement in predictive performance for mortality by combining tests.
    J Gastroenterol Hepatol. 2017;32:1240-1249.
    >> Share

    May 2017
  382. LIU CH, Liu CJ, Hong CM, Su TH, et al
    A noninvasive diagnosis of hepatic fibrosis by BioFibroScore(R) in chronic hepatitis C patients.
    J Gastroenterol Hepatol. 2017 May 26. doi: 10.1111/jgh.13834.
    >> Share

  383. SVIKLANE L, Olmane E, Dzerve Z, Kupcs K, et al
    Fatty liver index and hepatic steatosis index predict non-alcoholic fatty liver disease in type 1 diabetes.
    J Gastroenterol Hepatol. 2017 May 2. doi: 10.1111/jgh.13814.
    >> Share

  384. KIM JH, Lim KS, Min YW, Lee H, et al
    Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
    J Gastroenterol Hepatol. 2017;32:1064-1070.
    >> Share

  385. MAIA L, Ferreira JM, Pedroto I
    Hepatobiliary and Pancreatic: Unusual cause of acute pancreatitis.
    J Gastroenterol Hepatol. 2017;32:948.
    >> Share

  386. JUN DW, Kim SG, Park SH, Jin SY, et al
    External validation of the non-alcoholic fatty liver disease fibrosis score for assessing advanced fibrosis in Korean patients.
    J Gastroenterol Hepatol. 2017;32:1094-1099.
    >> Share

  387. PARKER R, Hodson J, Rowe IAC
    Systematic review: Current evidence in non-alcoholic fatty liver disease lacks relevance to patients with advanced fibrosis.
    J Gastroenterol Hepatol. 2017;32:950-956.
    >> Share

  388. RASHID HO, Kim HK, Junjappa R, Kim HR, et al
    Endoplasmic reticulum stress in the regulation of liver diseases: Involvement of Regulated IRE1alpha and beta-dependent decay and miRNA.
    J Gastroenterol Hepatol. 2017;32:981-991.
    >> Share

    April 2017
  389. ITO K, Murotani K, Nakade Y, Inoue T, et al
    Serum WFA+ -M2BP levels predict liver fibrosis, development of hepatocellular carcinoma, and overall survival: A meta-analysis.
    J Gastroenterol Hepatol. 2017 Apr 12. doi: 10.1111/jgh.13802.
    >> Share

  390. BASIR DN, Telisinghe PU, Bickle I, Chong VH, et al
    Hepatobiliary and Pancreatic: Malignant rhabdoid tumor of the liver.
    J Gastroenterol Hepatol. 2017;32:738.
    >> Share

  391. LOURENCO LC, Horta DV, Reis J
    Hepatobiliary and Pancreatic: Gastric outlet obstruction from pancreatitis-induced intramural duodenal haematoma.
    J Gastroenterol Hepatol. 2017;32:739.
    >> Share

  392. LIU PH, Hsu CY, Hsia CY, Lee YH, et al
    ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.
    J Gastroenterol Hepatol. 2017;32:879-886.
    >> Share

  393. NJEI B, McCarty TR, Laine L
    Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding.
    J Gastroenterol Hepatol. 2017;32:852-858.
    >> Share

    March 2017
  394. JIANG T, Du F, Qin N, Lu Q, et al
    Systematical analyses of variants in DNase I hypersensitive sites identified two novel hepatocellular carcinoma susceptibility loci among Chinese population.
    J Gastroenterol Hepatol. 2017 Mar 20. doi: 10.1111/jgh.13790.
    >> Share

  395. MIYATA T, Yamashita Y, Yamao T, Umezaki N, et al
    Hepatobiliary and Pancreatic: Hepatocellular carcinoma developed with angiomyolipoma.
    J Gastroenterol Hepatol. 2017;32:547.
    >> Share

  396. HWANG HE, Tseng HS, Liu CA, Chiou YY, et al
    Hepatobiliary and Pancreatic: Obstructive jaundice after transarterial chemoembolization of hepatocellular carcinoma related to intraductal tumor necrotic fragment.
    J Gastroenterol Hepatol. 2017;32:546.
    >> Share

  397. ZENG XQ, Ma LL, Tseng YJ, Chen J, et al
    Endoscopic cyanoacrylate injection with or without lauromacrogol for gastric varices: A randomized pilot study.
    J Gastroenterol Hepatol. 2017;32:631-638.
    >> Share

    February 2017
  398. CHONG CC, Wong GL, Chan AW, Wong VW, et al
    Liver stiffness measurement predicts high-grade post-hepatectomy liver failure: A prospective cohort study.
    J Gastroenterol Hepatol. 2017;32:506-514.
    >> Share

  399. SHI KQ, Cai YJ, Lin Z, Dong JZ, et al
    Development and validation of a prognostic nomogram for acute-on-chronic hepatitis B liver failure.
    J Gastroenterol Hepatol. 2017;32:497-505.
    >> Share

    January 2017
  400. POLLOCK G, Minuk GY
    Diagnostic Considerations for Cholestatic Liver Disease.
    J Gastroenterol Hepatol. 2017 Jan 20. doi: 10.1111/jgh.13738.
    >> Share

  401. RATHOD K, Deshmukh H, Shukla A, Popat B, et al
    Endovascular treatment of Budd-Chiari syndrome: Single center experience.
    J Gastroenterol Hepatol. 2017;32:237-243.
    >> Share

  402. CHOI HJ, Moon JH, Kim HK, Lee YN, et al
    KRAS mutation analysis by next-generation sequencing in endoscopic ultrasound-guided sampling for solid liver masses.
    J Gastroenterol Hepatol. 2017;32:154-162.
    >> Share

    October 2016
  403. MINAKARI M, Badihian S, Jalalpour P, Sebghatollahi V, et al
    Etiology and outcome in patients with upper gastrointestinal bleeding: Study on 4747 patients in the central region of Iran.
    J Gastroenterol Hepatol. 2016 Oct 17. doi: 10.1111/jgh.13617.
    >> Share

    July 2016
  404. PARK TY, Lee SK, Nam K, Oh D, et al
    Spontaneous hemobilia after liver transplantation: frequency, risk factors, and outcome of endoscopic management.
    J Gastroenterol Hepatol. 2016 Jul 23. doi: 10.1111/jgh.13497.
    >> Share

    May 2016
  405. OGURA T, Onda S, Takagi W, Sano T, et al
    Clinical utility of Endoscopic ultrasound-guided biliary drainage as a rescue of re-intervention procedure for high-grade hilar stricture.
    J Gastroenterol Hepatol. 2016 May 9. doi: 10.1111/jgh.13437.
    >> Share

    December 2015
  406. EATON JE, Dzyubak B, Venkatesh SK, Smyrk TC, et al
    Performance of magnetic resonance elastography in primary sclerosing cholangitis.
    J Gastroenterol Hepatol. 2015 Dec 21. doi: 10.1111/jgh.13263.
    >> Share

    November 2015
  407. ADAMS LA, Arauz O, Angus PW, Sinclair M, et al
    The additive impact of pre-liver transplant metabolic factors on survival post-liver transplant.
    J Gastroenterol Hepatol. 2015 Nov 21. doi: 10.1111/jgh.13240.
    >> Share

  408. KIM Y, Lee EJ, Jang HK, Kim CH, et al
    Statin pretreatment inhibits the LPS-induced EMT via the downregulation of TLR4 and NF-kappaB in human biliary epithelial cells.
    J Gastroenterol Hepatol. 2015 Nov 17. doi: 10.1111/jgh.13230.
    >> Share

    October 2015
  409. WANG D, Wang Q, Yin J, Dong R, et al
    Combined administration of propranolol plus AG490 offers better effects on portal hypertensive rats with cirrhosis.
    J Gastroenterol Hepatol. 2015 Oct 21. doi: 10.1111/jgh.13207.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016